10-Q

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 10-Q

☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934

For the quarterly period ended November 03, 2018

or

☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934

For the transition period from to

Commission file number 0-21196

Destination Maternity Corporation

(Exact name of registrant as specified in its charter)

Delaware	13-3045573
(State or other jurisdiction of incorporation or organization)	(IRS Employer Identification No.)
232 Strawbridge Drive Moorestown, New Jersey	08057
(Address of principal executive offices)	(Zip code)

(856) 291-9700

Registrant’s telephone number, including area code

Indicate by check mark whether the Registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.    Yes  ☒    No  ☐

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§ 232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).    Yes  ☒    No  ☐

Indicate by check mark whether the Registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, smaller reporting company or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act.

Large accelerated filer	☐	Accelerated filer	☐
Non-accelerated filer	☐	Smaller reporting company	☒
Emerging growth company	☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act    ☐

Indicate by check mark whether the Registrant is a shell company (as defined in Rule 12b-2 of the Act).    Yes  ☐    No   ☒

Indicate the number of shares outstanding of each of the issuer’s classes of common stock, as of the latest practicable date.

Common Stock, $.01 par value — 14,447,524 shares outstanding as of November 30, 2018

DESTINATION MATERNITY CORPORATION AND SUBSIDIARIES

INDEX

PART I. FINANCIAL INFORMATION
Item 1.	Financial Statements (unaudited)	3
	Consolidated Balance Sheets	3
	Consolidated Statements of Operations	4
	Consolidated Statements of Comprehensive Income (Loss)	5
	Consolidated Statements of Stockholders’ Equity	6
	Consolidated Statements of Cash Flows	7
	Notes to Consolidated Financial Statements	8
Item 2.	Management’s Discussion and Analysis of Financial Condition and Results of Operations	19
Item 3.	Quantitative and Qualitative Disclosures About Market Risk	31
Item 4.	Controls and Procedures	32
PART II. OTHER INFORMATION
Item 1.	Legal Proceedings	33
Item 1A.	Risk Factors	33
Item 2.	Unregistered Sales of Equity Securities and Use of Proceeds	33
Item 6.	Exhibits	34
Signatures		35

2

PART I—FINANCIAL INFORMATION

Item 1. Financial Statements

DESTINATION MATERNITY CORPORATION AND SUBSIDIARIES

CONSOLIDATED BALANCE SHEETS

(in thousands, except share and per share amounts)

(unaudited)

	November 3, 2018			February 3, 2018
ASSETS
Current assets:
Cash and cash equivalents	$	1,247		$	1,635
Trade receivables, net		7,261			6,692
Inventories		79,054			71,256
Prepaid expenses and other current assets		10,270			11,522
Total current assets		97,832			91,105
Property and equipment, net of accumulated depreciation and amortization of    $106,276 and $98,024		55,158			66,146
Other assets:
Deferred line of credit financing costs, net of accumulated amortization of    $898 and $829		383			450
Other intangible assets, net of accumulated amortization of $1,027 and $907		863			953
Deferred income taxes		4,805			2,829
Other non-current assets		1,064			1,099
Total other assets		7,115			5,331
Total assets	$	160,105		$	162,582
LIABILITIES AND STOCKHOLDERS’ EQUITY
Current liabilities:
Line of credit borrowings	$	21,700		$	8,000
Current portion of long-term debt		4,729			4,780
Accounts payable		25,767			30,949
Accrued expenses and other current liabilities		30,988			31,661
Total current liabilities		83,184			75,390
Long-term debt		22,704			23,809
Deferred rent and other non-current liabilities		20,856			22,715
Total liabilities		126,744			121,914
Commitments and contingencies (Note 15)
Stockholders’ equity:
Preferred stock, 1,656,381 shares authorized, none outstanding		—			—
Common stock, $.01 par value; 20,000,000 shares authorized, 14,447,524 and    14,684,117 shares issued and outstanding		145			147
Additional paid-in capital		107,482			106,865
Accumulated deficit		(74,192	)		(66,274	)
Accumulated other comprehensive loss		(74	)		(70	)
Total stockholders’ equity		33,361			40,668
Total liabilities and stockholders’ equity	$	160,105		$	162,582

The accompanying notes are an integral part of these consolidated financial statements.

3

DESTINATION MATERNITY CORPORATION AND SUBSIDIARIES

CONSOLIDATED STATEMENTS OF OPERATIONS

(in thousands, except per share amounts)

(unaudited)

	Three Months Ended						Nine Months Ended
	November 3, 2018			October 28, 2017			November 3, 2018			October 28, 2017
Net sales	$	92,837		$	96,354		$	292,459		$	301,060
Cost of goods sold		44,181			45,453			138,535			140,167
Gross profit		48,656			50,901			153,924			160,893
Selling, general and administrative expenses		48,629			53,234			150,581			161,689
Store closing, asset impairment and asset disposal expenses		1,028			1,011			2,669			3,649
Other charges, net		1,825			3,100			4,898			3,746
Operating loss		(2,826	)		(6,444	)		(4,224	)		(8,191	)
Interest expense, net		1,232			1,006			3,533			2,989
Loss before income taxes		(4,058	)		(7,450	)		(7,757	)		(11,180	)
Income tax provision		56			73			168			259
Net loss	$	(4,114	)	$	(7,523	)	$	(7,925	)	$	(11,439	)
Net loss per share— Basic	$	(0.30	)	$	(0.55	)	$	(0.57	)	$	(0.83	)
Average shares outstanding— Basic		13,895			13,800			13,867			13,777
Net loss per share— Diluted	$	(0.30	)	$	(0.55	)	$	(0.57	)	$	(0.83	)
Average shares outstanding— Diluted		13,895			13,800			13,867			13,777

The accompanying notes are an integral part of these consolidated financial statements.

4

DESTINATION MATERNITY CORPORATION AND SUBSIDIARIES

CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (LOSS)

(in thousands)

(unaudited)

	Three Months Ended						Nine Months Ended
	November 3, 2018			October 28, 2017			November 3, 2018			October 28, 2017
Net loss	$	(4,114	)	$	(7,523	)	$	(7,925	)	$	(11,439	)
Foreign currency translation adjustments		(2	)		—			(4	)		2
Comprehensive loss	$	(4,116	)	$	(7,523	)	$	(7,929	)	$	(11,437	)

The accompanying notes are an integral part of these consolidated financial statements.

5

DESTINATION MATERNITY CORPORATION AND SUBSIDIARIES

CONSOLIDATED STATEMENTS OF STOCKHOLDERS’ EQUITY

(in thousands)

(unaudited)

	Common Stock												Accumulated
	Number of Shares			Amount			Additional Paid-in Capital			Accumulated Deficit			Other Comprehensive Loss			Total
Balance as of February 3, 2018		14,684		$	147		$	106,865		$	(66,274	)	$	(70	)	$	40,668
Net loss		—			—			—			(7,925	)		—			(7,925	)
Foreign currency translation adjustments		—			—			—			—			(4	)		(4	)
Dividends forfeited		—			—			—			7			—			7
Stock-based compensation		477			5			745			—			—			750
Exercise of stock options, net		0			0			1			—			—			1
Repurchase and retirement of common stock		(683	)		(7	)		(129	)		—			—			(136	)
Balance as of November 3, 2018		14,478		$	145		$	107,482		$	(74,192	)	$	(74	)	$	33,361
Balance as of January 28, 2017		14,010		$	140		$	105,775		$	(44,693	)	$	(72	)	$	61,150
Net loss		—			—			—			(11,439	)		—			(11,439	)
Foreign currency translation adjustments		—			—			—			—			2			2
Dividends forfeited		—			—			—			15			—			15
Stock-based compensation		616			6			852			—			—			858
Repurchase and retirement of common stock		(15	)		—			(45	)		—			—			(45	)
Balance as of October 28, 2017		14,611		$	146		$	106,582		$	(56,117	)	$	(70	)	$	50,541

The accompanying notes are an integral part of these consolidated financial statements.

6

DESTINATION MATERNITY CORPORATION AND SUBSIDIARIES

CONSOLIDATED STATEMENTS OF CASH FLOWS

(in thousands)

(unaudited)

	Nine Months Ended
	November 3, 2018			October 28, 2017
Operating Activities
Net loss	$	(7,925	)	$	(11,439	)
Adjustments to reconcile net loss to net cash provided    by operating activities:
Depreciation and amortization		11,789			13,259
Stock-based compensation expense		750			858
Loss on impairment of long-lived assets		2,236			3,267
Loss on disposal of assets		238			283
Grow NJ award benefit		(1,977	)		1,096
Amortization of deferred financing costs		506			375
Changes in assets and liabilities:
Decrease (increase) in:
Trade receivables		(569	)		(1,218	)
Inventories		(7,798	)		(4,896	)
Prepaid expenses and other current assets		1,251			3,110
Other non-current assets		35			(59	)
(Decrease) increase in:
Accounts payable, accrued expenses and other current liabilities		(3,861	)		2,474
Deferred rent and other non-current liabilities		(2,087	)		23
Net cash provided by (used in) operating activities		(7,412	)		7,133
Investing Activities
Capital expenditures		(3,456	)		(5,484	)
Additions to intangible assets		—			(18	)
Net cash used in investing activities		(3,456	)		(5,502	)
Financing Activities
Decrease in cash overdraft		(1,486	)		(461	)
Increase in line of credit borrowings		13,700			3,600
Proceeds from long-term debt		2,500			3,401
Repayment of long-term debt		(3,935	)		(8,493	)
Deferred financing costs paid		(160	)		(277	)
Withholding taxes on stock-based compensation paid in connection    with repurchase of common stock		(136	)		(45	)
Proceeds from exercise of stock options		1			—
Net cash provided by (used in) financing activities		10,484			(2,275	)
Effect of exchange rate changes on cash and cash equivalents		(4	)		2
Net Decrease in Cash and Cash Equivalents		(388	)		(642	)
Cash and Cash Equivalents, Beginning of Period		1,635			2,859
Cash and Cash Equivalents, End of Period	$	1,247		$	2,217
Supplemental Disclosures of Cash Flow Information:
Cash paid for interest	$	2,997		$	2,640
Cash (received) paid for income taxes	$	118		$	(4,240	)

The accompanying notes are an integral part of these consolidated financial statements.

7

DESTINATION MATERNITY CORPORATION AND SUBSIDIARIES

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

(unaudited)

1. BASIS OF FINANCIAL STATEMENT PRESENTATION

The accompanying unaudited consolidated financial statements for the three and nine months ended November 3, 2018 and October 28, 2017 have been prepared in accordance with the requirements for Form 10-Q and Article 10 of Regulation S-X, and accordingly, certain information and footnote disclosures have been condensed or omitted. See the Company’s Annual Report on Form 10-K as of and for the year ended February 3, 2018 for Destination Maternity Corporation and subsidiaries (the “Company” or “Destination Maternity”) as filed with the Securities and Exchange Commission (“SEC”) for additional disclosures including a summary of the Company’s accounting policies.

In the opinion of management, the consolidated financial statements contain all adjustments, consisting of normal recurring adjustments, necessary to present fairly the consolidated financial position, results of operations and cash flows of the Company for the periods presented. Since the Company’s operations are seasonal, the interim operating results of the Company may not be indicative of operating results for the full year. Certain prior year amounts have been reclassified to conform to the current year presentation.

The Company operates on a 52/53-week fiscal year ending on the Saturday nearest January 31 of each year. References to the Company’s fiscal 2018 refer to the 52-week fiscal year, or periods within such fiscal year, which began February 4, 2018 and will end February 2, 2019. References to the Company’s fiscal 2017 refer to the 53-week fiscal year, or periods within such fiscal year, which began January 29, 2017 and ended February 3, 2018.

2. EARNINGS PER SHARE (“EPS”) AND DIVIDENDS

Basic net loss per share (“Basic EPS”) is computed by dividing net loss by the weighted average number of common shares outstanding, excluding restricted stock awards for which the restrictions have not lapsed. Diluted net loss per share (“Diluted EPS”) is computed by dividing net loss by the weighted average number of common shares outstanding, after giving effect to the potential dilution, if applicable, from the assumed lapse of restrictions on restricted stock and restricted stock unit (“RSU”) awards, and from shares of common stock resulting from the assumed exercise of outstanding stock options. Common shares issuable in connection with the award of performance-based restricted stock units (“PRSUs”) are excluded from the calculation of EPS until the PRSUs’ performance conditions are achieved and the shares in respect of the PRSUs become issuable (see Note 13).

The following tables summarize the Basic EPS and Diluted EPS calculations (in thousands, except per share amounts):

	Three Months Ended
	November 3, 2018								October 28, 2017
	Net Loss			Shares		EPS			Net Loss			Shares		EPS
Basic and Diluted EPS	$	(4,114	)		13,895	$	(0.30	)	$	(7,523	)		13,800	$	(0.55	)

	Nine Months Ended
	November 3, 2018								October 28, 2017
	Net Loss			Shares		EPS			Net Loss			Shares		EPS
Basic and Diluted EPS	$	(7,925	)		13,867	$	(0.57	)	$	(11,439	)		13,777	$	(0.83	)

In addition to PRSUs, for the three and nine months ended November 3, 2018 stock options and unvested restricted stock totaling approximately 436,000 and 804,000 shares, respectively, were excluded from the calculation of Diluted EPS as their effect would have been antidilutive. Stock options and unvested restricted stock totaling approximately 1,130,000 and 1,604,000 shares of the Company’s common stock were outstanding as of November 3, 2018 and October 28, 2017, respectively, but were not included in the computation of Diluted EPS for the three and nine months ended November 3, 2018 and October 28, 2017 due to the Company’s net loss. If the Company had reported a profit for the three and nine months ended November 3, 2018 and for the three and nine months ended October 28, 2017 the weighted average number of dilutive shares outstanding for computation of Diluted EPS would have been approximately 14,186,000, 14,159,000, 13,811,000 and 13,797,000 shares, respectively.

8

During the nine months ended November 3, 2018 and October 28, 2017, $7,000 and $15,000, respectively, of previously declared and undistributed dividends, for which payment was subject to completion of service requirements under restricted stock awards, were forfeited back to the Company in connection with the cancellation of the restricted stock awards.

3. TRADE RECEIVABLES

Trade receivables are recorded based on revenue recognized for sales of the Company’s merchandise and for other revenue earned by the Company through its marketing partnership programs and international franchise agreements, and are non-interest bearing. The Company evaluates the collectability of trade receivables based on a combination of factors, including aging of trade receivables, write-off experience, analysis of historical trends and expectations of future performance. An allowance for doubtful accounts is recorded for the amount of trade receivables that are considered unlikely to be collected. When the Company’s collection efforts are unsuccessful, uncollectible trade receivables are charged against the allowance for doubtful accounts. As of November 3, 2018, and February 3, 2018 the Company’s trade receivables were net of allowance for doubtful accounts of $166,000 and $166,000, respectively.

4. INVENTORIES

Inventories were comprised of the following (in thousands):

	November 3, 2018		February 3, 2018
Finished goods	$	78,711	$	70,687
Work-in-progress		142		182
Raw materials		201		387
	$	79,054	$	71,256

5. ACCRUED EXPENSES AND OTHER CURRENT LIABILITIES

Accrued expenses and other current liabilities were comprised of the following (in thousands):

	November 3, 2018		February 3, 2018
Employee compensation and benefits	$	6,256	$	7,133
Accrued expenses		4,866		3,244
Insurance, primarily self-insurance reserves		3,858		5,048
Deferred rent		2,983		3,211
Sales and use taxes		2,827		2,638
Gift certificates and store credits		2,832		3,385
Product return reserve		2,298		2,799
Deferred revenue		1,668		1,001
Audit and legal		1,399		714
Accrued property and equipment additions		185		218
Other		1,816		2,270
	$	30,988	$	31,661

6. LINE OF CREDIT

After completion of a debt refinancing on February 1, 2018 the Company has in place a $50,000,000 senior secured revolving credit facility (the “Credit Facility”), which was amended and restated in connection with the issuance of the Company’s $25,000,000 Term Loan (see Note 7). The Company’s previous $70,000,000 Credit Facility had been in place since March 25, 2016. In connection with the Term Loan financing the maturity date of the Credit Facility was extended to January 31, 2023 and certain availability reserves were reduced or eliminated. Proceeds from advances under the Credit Facility, subject to certain restrictions, may be used to provide financing for working capital, letters of credit, capital expenditures, and other general corporate purposes.

9

The Credit Facility contains various affirmative and negative covenants and representations and warranties including the requirement that the Company maintain Excess Availability (as defined in the related Credit Agreement) of more than the greater of 10% of the Combined Loan Caps (as defined in the related Credit Agreement) and $7,000,000. In the event that the outstanding balance of the Term Loan exceeds the Term Loan Borrowing Base (as defined in the related Term Loan Agreement) then a reserve will be imposed against availability under the Credit Facility. The Credit Facility is secured by a security interest in the Company’s trade receivables, inventory, letter of credit rights, cash, intangibles and certain other assets. The interest rate on outstanding borrowings is equal to, at the Company’s election, either 1) the lender’s base rate plus 0.50% or 2) a LIBOR rate plus 1.0%. The Company also pays an unused line fee under the Credit Facility of 0.25% per annum.

Any amounts outstanding under the Credit Facility may be accelerated and become due and payable immediately and all loan and letter of credit commitments thereunder may be terminated upon an event of default and expiration of any applicable cure period. Events of default include: 1) nonpayment of obligations due under the subject loan agreement and related loan documents, 2) cross-defaults to other indebtedness and documents, 3) failure to perform any covenant or agreement contained in the subject loan agreement, 4) material misrepresentations, 5) failure to pay, or certain other defaults under, other material indebtedness of the Company, 6) certain bankruptcy or insolvency events, 7) a change of control, 8) indictments of the Company or senior management in a material forfeiture action, 9) default under certain material contracts to the extent such termination or default has or could reasonably be expected to have a material adverse effect, and 10) customary ERISA defaults, among others.

In connection with the original execution and subsequent amendments of the Credit Facility, the Company incurred deferred financing costs of $1,280,000.  These deferred financing costs are being amortized over the term of the Credit Facility agreement and are included in “interest expense, net” in the consolidated statements of operations.

As of November 3, 2018, the Company had $21,700,000 in outstanding borrowings under the Credit Facility, $7,327,000 in letters of credit and $13,505,000 of availability based on the Company’s Borrowing Base formula and availability reserve requirements. As of October 28, 2017, the Company had $8,200,000 in outstanding borrowings under the previous Credit Facility, $7,327,000 in letters of credit and $12,531,000 of availability. For the three months ended November 3, 2018 and October 28, 2017 borrowings had a weighted interest rate of 4.22% and 3.87% per annum, respectively. For the nine months ended November 3, 2018 and October 28, 2017 borrowings had a weighted interest rate of 4.11% and 3.51% per annum, respectively.  During the nine months ended November 3, 2018 and October 28, 2017 the Company’s average levels of direct borrowings were $17,258,000 and $8,707,000, respectively, and the Company’s maximum borrowings were $27,400,000 and $15,700,000, respectively.

On September 26, 2018, the Company entered into a commitment letter with Bank of America N.A. (“Bank of America”),, pursuant to which, and subject to the terms and conditions set forth therein, Bank of America committed to provide to the Company certain five-year asset-based senior secured facilities consisting of an ABL with an aggregate commitment of $52 million and a FILO Term Loan with an aggregate principal amount of $24 million. The interest rates are expected to be, at the Company’s option, adjusted LIBOR or base rate plus an applicable margin based on excess availability. Such applicable margins for the base rate loans expect to range between 0.50% and 1.00% per annum in the case of the ABL and between 2.25% and 2.75% per annum in the case of the FILO Term Loan. Such applicable margins for the LIBOR loans expect to range between 1.5% to 2.0% in the case of the ABL and between 3.25% to 3.75% in the case of the FILO Term Loan. The funding of the senior secured facilities under the commitment letter is contingent upon the satisfaction of customary conditions, including, but not limited to, the parties’ entering into definitive documentation, absence of material adverse events or conditions with respect to the Company and the receipt of payoff letters in respect of the Company’s existing credit agreements governing its outstanding indebtedness. It is anticipated that the Company will use the net proceeds of the senior secured facilities to repay outstanding indebtedness under its Term Loan previously discussed in this Note 7 and under its Credit Facility previously discussed in Note 6, pay a portion of the transaction fees and expenses in connection with entering into the senior secured facilities and to the extent any net proceeds remain, for ongoing working capital and other general corporate purposes of the Company.

7. LONG-TERM DEBT

On February 1, 2018 (the “Closing Date”) the Company entered into a Term Loan Credit Agreement (the “Term Loan Agreement”) which provides for a term loan of up to $25,000,000 and matures on January 31, 2023 (the “Term Loan”).  On the Closing Date the Company borrowed $22,500,000 net of fees against the Term Loan and used the proceeds, in addition to $3,600,000 borrowed under its Credit Facility (see Note 6) to pay off the $22,999,000 balance of the Company’s then existing term loan (the “Prior Term Loan”) and $3,226,000 of fees and interest associated with the refinancing transaction. The Term Loan provided for an additional loan of $2,500,000 which could be borrowed at the Company’s discretion within a period of 45 days after delivery to the lender of the Company’s first quarter fiscal 2018 financial statements and satisfaction of certain other requirements. The Company met these requirements and borrowed the additional $2,500,000 on July 16, 2018. There is a minimum excess availability requirement of the greater of 10% of the Combined Loan Cap, as defined in the Term Loan Agreement, or $7,000,000.    

10

The interest rate on the Term Loan is equal to a LIBOR rate plus 9.0%. The Company is required to make minimum repayments of the principal amount of the Term Loan in quarterly installments of $312,500 which commenced on July 31, 2018, with the remaining outstanding balance payable on the maturity date. Additionally, the Term Loan can be prepaid at the Company's option subject to certain restrictions and subject to a prepayment premium as follows: 1) if the prepayment occurs on or prior to the second anniversary of the Closing Date, the greater of  a) interest on the prepayment that would otherwise have been paid with the 24 month period following the Closing Date minus actual interest payments made through the prepayment date and b) 2% of the prepayment and 2) 2% of the prepayment amount if paid between the second and third anniversary of the Closing Date.

The Term Loan is secured by a security interest in substantially all of the assets of the Company, including accounts receivable, inventory, equipment, letter of credit rights, cash, intellectual property and other intangibles, and certain other assets. The security interest granted to the Term Lenders is, in certain respects, subordinate to the security interest granted to the Credit Facility Lender. The Term Loan Agreement prohibits the payment of dividends or share repurchases by the Company for three years and imposes certain restrictions on the Company's ability to, among other things, incur additional indebtedness and enter into other various types of transactions.

On September 26, 2018, the Company entered into a commitment letter with Bank of America, pursuant to which, and subject to the terms and conditions set forth therein, Bank of America committed to provide to the Company certain five-year asset-based senior secured facilities consisting of an ABL with an aggregate commitment of $52 million and a FILO Term Loan with an aggregate principal amount of $24 million. The interest rates are expected to be, at the Company’s option, adjusted LIBOR or base rate plus an applicable margin based on excess availability. Such applicable margins for the base rate loans expect to range between 0.50% and 1.00% per annum in the case of the ABL and between 2.25% and 2.75% per annum in the case of the FILO Term Loan. Such applicable margins for the LIBOR loans expect to range between 1.5% to 2.0% in the case of the ABL and between 3.25% to 3.75% in the case of the FILO Term Loan. The funding of the senior secured facilities under the commitment letter is contingent upon the satisfaction of customary conditions, including, but not limited to, the parties’ entering into definitive documentation, absence of material adverse events or conditions with respect to the Company and the receipt of payoff letters in respect of the Company’s existing credit agreements governing its outstanding indebtedness. It is anticipated that the Company will use the net proceeds of the senior secured facilities to repay outstanding indebtedness under its Term Loan previously discussed in this Note 7 and under its Credit Facility previously discussed in Note 6, pay a portion of the transaction fees and expenses in connection with entering into the senior secured facilities and to the extent any net proceeds remain, for ongoing working capital and other general corporate purposes of the Company.

On March 25, 2016 the Company entered into a Term Loan Agreement Credit Agreement (the “Prior Term Loan Agreement”) for the Company’s $32,000,000 Prior Term Loan that had a maturity date of March 25, 2021. The proceeds of the Prior Term Loan were used to repay a portion of the indebtedness that was outstanding under the Company’s credit facility at that time.  The interest rate on the Prior Term Loan was equal to a LIBOR rate (with a 1.0% LIBOR floor) plus 7.5%. The Company was required to make minimum repayments of the principal amount in quarterly installments of $800,000 with the remaining outstanding balance payable on the maturity date.  As amended on December 19, 2016 and April 7, 2017, the Prior Term Loan Agreement contained various minimum excess availability requirements including $5,000,000 against availability under the Company Credit Facility that was reduced dollar for dollar for prepayments of the Prior Term Loan, and an amount equal to the greater of 10% of the Combined Loan Cap (as defined in the Credit Facility Agreement) or $10,000,000.

In connection with the execution of the Term Loan Agreement, the Prior Term Loan Agreement and subsequent amendments, the Company incurred deferred financing costs of $4,557,000. Of this amount, the unamortized balance of $1,542,000 in deferred financing costs incurred in connection with the Prior Term Loan were written off upon entering into the Term Loan and charged to loss on extinguishment of debt in the Company consolidated statements of operations. There were $2,460,000 of deferred financing costs incurred in connection with the Term Loan. These deferred financing costs are reflected as a direct deduction from the Term Loan liability in the consolidated balance sheets and are being amortized over the term of the Term Loan Agreement. The amortization is included in “interest expense, net” in the consolidated statements of operations.

As of November 3, 2018, and October 28, 2017 there was $24,375,000 and $24,599,000, respectively, of principal outstanding under the Term Loan and Prior Term Loan.

As of November 3, 2018, and October 28, 2017 there was $3,730,000 and $7,064,000, respectively, outstanding under a five-year equipment financing arrangement with the Company’s Credit Facility bank. The equipment note bears annual interest at 3.38%, with payments of $272,000 (including interest) due monthly through December 2019. The equipment note is collateralized by substantially all of the material handling equipment at the Company’s distribution facility in Florence, New Jersey. Any amounts outstanding under the equipment note may be accelerated and become due and payable immediately upon an event of default and expiration of any applicable cure period. The specified events of default are substantially the same as those in the Credit Facility agreement (see Note 6).

11

On June 6, 2017 the Company received $3,401,000 in proceeds from a three-year financing arrangement in the form of a sale and leaseback for certain furniture, fixtures and software. Monthly payments under the leaseback arrangement are $123,000 for the first 24 months and $48,000 for months 25 to 36. At the end of the leaseback term, the Company has the option to extend the lease for an additional year or to repurchase the financed property for a price to be agreed. All of the proceeds from the transaction were used to prepay a portion of the Company’s Term Loan.  As of November 3, 2018, and October 28, 2017, there was $1,680,000 and $2,947,000 of principal outstanding under this financing arrangement.

8. FAIR VALUE MEASUREMENTS

The accounting standard for fair value measurements defines fair value as the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. The standard establishes a framework for measuring fair value focused on exit price and creates a fair value hierarchy in order to increase the consistency and comparability of fair value measurements as follows:

• Level 1 – Quoted market prices in active markets for identical assets or liabilities

• Level 2 – Observable market-based inputs or inputs that are corroborated by observable market data

• Level 3 – Unobservable inputs that are not corroborated by market data

At both November 3, 2018 and February 3, 2018, the Company had cash equivalents of $4,000. The Company’s cash equivalents consist of investments in money market funds for which the carrying value approximates fair value (based on Level 1 inputs) due to the short-term nature of those instruments. The carrying values of trade receivables and accounts payable approximate fair value due to the short-term nature of those instruments.

The Company’s Credit Facility has variable interest rates that are tied to market indices. As of November 3, 2018, and February 3, 2018, the Company had $21,700,000 and $8,000,000, respectively, of direct borrowings outstanding under the Credit Facility. The carrying value of the Company’s Credit Facility borrowings approximates fair value as the variable interest rates approximate current market rates, which the Company considers to be Level 2 inputs.

The Company’s Term Loan, which represents a significant majority of the Company’s long-term debt, bears interest at variable rates, which adjust based on market conditions with a minimum annual rate of 9.00%. The carrying value of the Company’s Term Loan approximates fair value as the variable interest rates approximate current market rates for similar instruments available to companies with comparable credit quality, which the Company considers to be Level 2 inputs. The fair value of the Company’s fixed-rate equipment notes was determined using a discounted cash flow analysis based on interest rates currently available to the Company, which the Company considers to be Level 2 inputs. The difference between the carrying value and fair value of long-term debt held by the Company with a fixed rate of interest is not material.

9. NET SALES

The following disaggregates the Company’s net sales by major source (in thousands):

	Three Months Ended				Nine Months Ended
	November 3, 2018		October 28, 2017		November 3, 2018		October 28, 2017
Retail stores	$	55,979	$	59,325	$	177,608	$	191,664
Leased departments		9,743		10,292		29,624		32,752
Total retail locations		65,722		69,617		207,232		224,416
Ecommerce		21,045		20,539		69,530		57,615
Marketing partnerships		4,110		4,475		12,236		13,004
Wholesale and franchise		1,960		1,723		3,461		6,025
Total net sales	$	92,837	$	96,354	$	292,459	$	301,060

The Company’s performance obligations consist primarily of transferring control of merchandise to customers.  Retail and ecommerce sales are recognized upon transfer of control, which occurs when merchandise is taken at point-of-sale for a retail transaction or upon receipt of shipment for an ecommerce transaction.  Sales are reported net of returns and sales taxes.  Shipping and handling fees billed to customers are recognized in net sales when control of the underling merchandise is transferred to the customer.

12

The Company earns revenue through a variety of marketing partnership programs utilizing the Company’s opt-in customer database and various in-store marketing initiatives focused on baby and parent-related products and services.  Revenue from these activities is recognized when the goods or services are provided.

Sales of product to the Company’s wholesale customers and international franchisees are recognized upon transfer of control which is primarily when product is shipped.  Franchise fees are recorded by the Company when all material services have been performed or in the case of royalties earned on sales of product, in the period when the franchisee sells product to their retail customer.

10. OTHER CHARGES, NET

In the first quarter of fiscal 2018 the Company received notification from a stockholder group (the “Stockholder Group”), of the nomination of a slate of alternative nominees for election to the Company’s Board of Directors at the Annual Meeting of Stockholders that was held on May 23, 2018 (the “Proxy Solicitation”).  At the Company’s 2018 Annual Meeting of Stockholders held on May 23, 2018, the Company’s stockholders replaced the incumbent board in its entirety and elected Holly N. Alden, Christopher B. Morgan, Marla A Ryan and Anne-Charlotte Windal as the Company’s new Board of Directors. During the nine months ended November 3, 2018 the Company incurred $2,224,000 of charges related to the Proxy Solicitation, including $83,000 during the three months ended November 3, 2018.

During the fourth quarter of fiscal 2015 the Company entered into an Agreement and Plan of Merger (the “Merger Agreement”) with the Company’s largest shareholder, Orchestra, a France-based retailer of children’s wear, to complete a proposed business combination (“the Proposed Merger”).  During the second quarter of fiscal 2017 the parties determined that is was in the best interest of their respective stockholders to terminate the Merger and on July 27, 2017, the Company, Orchestra, and certain other affiliates of Orchestra entered into a Termination Agreement (the “Termination Agreement”).   In connection with the Termination Agreement, Orchestra and the Company agreed to reimburse each other for certain costs incurred in connection with their effort to implement the Merger Agreement.  During the nine months ended October 28, 2017 the Company incurred $1,113,000 of charges related to the proposed merger.

Over the last several years the Company has engaged in a series of management and organizational changes and, in connection therewith, retained consulting firms to review its costs and business strategy associated with such management and organizational changes.  The Company’s Board of Directors authorized changes to the Company’s chief executive function including the resignation of Anthony M. Romano as the Company’s Chief Executive Officer and President,  the September 17, 2017 appointment of B. Allen Weinstein, an independent member of the Company’s Board since 2010, as Interim Chief Executive Officer replacing Mr. Romano, the January 2, 2018 appointment of Melissa Payner-Gregor, an independent  member of the Company’s Board since 2009, as Interim Chief Executive Officer replacing Mr. Weinstein and the May 23, 2018 appointment of Marla Ryan as Chief Executive Officer replacing Ms. Payner-Gregor.  Ronald Masciantonio, the Company’s Chief Administrative Officer, resigned from his position on June 4, 2018.  David Stern, the Company’s former Chief Financial Officer departed the Company effective at the close of business on August 10, 2018. The Company also paid one-time retention bonuses with service conditions to certain key management personnel which are being recorded over the service period, while reducing its overall headcount to create a more efficient and effective operating structure. During the three and nine months ended November 3, 2018 and October 28, 2017 the Company incurred $1,742,000, $2,636,000, $2,674,000 and $2,633,000, respectively, of charges related to these management and organizational changes.

A summary of the net charges incurred in connection with the proxy solicitation and proposed merger and the management and organizational changes is as follows (in thousands):

	Three Months Ended				Nine Months Ended
	November 3, 2018		October 28, 2017		November 3, 2018		October 28, 2017
Proxy Solicitation and Proposed Merger
Proxy solicitation	$	83	$	—	$	2,224	$	—
Proposed merger		—		464		—		1,113
Total proxy solicitation and proposed    merger		83		464		2,224		1,113
Management and Organizational Changes
Severance and related benefits		1,252		2,139		2,136		2,136
Consulting fees		490		497		538		497
Total management and organizational    changes		1,742		2,636		2,674		2,633
Total other charges, net	$	1,825	$	3,100	$	4,898	$	3,746

13

11. GOVERNMENT INCENTIVES

In fiscal 2015 the Company completed the relocation of its corporate headquarters and distribution operations from Philadelphia, Pennsylvania to southern New Jersey. To partially offset the costs of these relocations, the Board of the New Jersey Economic Development Authority (“NJEDA”) approved the Company for an incentive package of up to $40,000,000 in benefits under the Grow New Jersey Assistance Program (“Grow NJ”) in the form of transferrable income tax credits over a ten-year period from the State of New Jersey. The award provides annually over a ten-year period up to $7,000 per eligible new full-time job, as defined under Grow NJ, with a requirement that at least 100 eligible jobs be created and subject to an annual award limit of $4,000,000.

The Grow NJ award requires an annual compliance report that includes certification of average annual employment figures after the end of each fiscal year. After the end of the ten-year Grow NJ award earnings period there is a five-year compliance period during which the Company must maintain the average of its annual eligible jobs certified during the preceding ten years or a pro-rata amount up to one-tenth of the previously awarded income tax credits would be subject to recapture and repayment to the State of New Jersey annually during the five-year compliance period. The Company believes the likelihood of any recapture and repayment is remote.

The annual benefit from the Grow NJ award available to the Company is expected to significantly exceed the Company’s annual income tax liability to the State of New Jersey. In order to maximize the realizable value of the incentive package, in December 2013 the Company entered into an agreement with a third party to sell 75% or more of the annual income tax credits awarded to the Company. The Company recognizes its Grow NJ award on an annual basis for each fiscal year based on the realizable value of the award earned and expected to be received, primarily from the sale of the income tax credits, net of any associated costs. The Grow NJ award is reflected in the Company’s consolidated financial statements as a reduction to the costs incurred by the Company in connection with the relocations. The expected realizable amount of the Grow NJ award is included in the consolidated balance sheet in deferred income taxes. As of November 3, 2018, the Company had recorded a deferred tax asset of $4,805,000 related to the NJ Grow award. Of this amount, $2,829,000 relates to the annual award earned in fiscal 2017, the cash proceeds of which is expected to be received in the fourth quarter of fiscal 2018. In April 2017, the Company received $3,251,000 cash proceeds, net of costs, from the receipt and subsequent sale of the $3,612,000 tax credit certificate earned for fiscal 2016. During the three and nine months ended November 3, 2018, the Company recognized the cost reduction related to the Grow NJ award in the amount of $617,000 and $1,902,000, respectively, as compared to the three and nine months ended October 28, 2017 in which the Company recognized $718,000 and $2,155,000 respectively.

12. INCOME TAXES

The U.S. Tax Cuts and Jobs Act of 2017 (the “TCJA”) was signed into law on December 22, 2017.  The TCJA included a number of changes to the U.S. corporate income tax including a reduction of the corporate income tax rate from 35% to 21% for tax years beginning after December 31, 2017.  For fiscal 2018 the Company’s effective federal tax rate is 21%.  For fiscal 2017 the Company used a blended effective tax rate of 33.7% which represented the prorated percentage from the TCJA’s January 1, 2018 effective date and the Company’s February 3, 2018 fiscal year-end.  

Accounting Standards Codification (“ASC”) Topic 740, Income Taxes, requires that a valuation allowance be recorded to reduce deferred tax assets when it is more likely than not that the tax benefit of the deferred tax assets will not be realized. In situations where a three-year cumulative loss condition exists, accounting standards limit the ability to consider projections of future results as positive evidence to assess the realizability of deferred tax assets.  In fiscal 2016 the Company’s financial results reflected a three-year cumulative loss. Consequently, in fiscal 2016 the Company recorded a non-cash charge as a valuation allowance against substantially all of its deferred tax assets.  Three-year cumulative losses have continued in fiscal 2017 and fiscal 2018, consequently the Company continues to record a valuation allowance against its deferred tax assets.

13. EQUITY AWARD PLANS

In January 2006, the stockholders of the Company approved the adoption of the Amended and Restated 2005 Equity Incentive Plan (the “2005 Plan”) and, subsequently, have approved amendments to increase the number of issuable shares under the 2015 Plan. Under the 2005 Plan, employees, directors, consultants and other individuals who provide services to the Company may be granted awards in the form of stock options, stock appreciation rights, restricted stock, RSU’s or deferred stock units. Up to 3,550,000 shares of the Company’s common stock may be issued in respect of awards under the 2005 Plan, as amended, with no more than 2,250,000 of those shares permitted to be issued in respect of restricted stock, RSU’s, or deferred stock units granted under the 2005 Plan. Awards of stock options to purchase the Company’s common stock will have exercise prices as determined by the Compensation Committee of the Board of Directors (the “Compensation Committee”), but such exercise prices may not be lower than the fair market value of the stock on the date of grant.

14

No stock options have been granted by the Company with an exercise price less than the fair market value of the Company’s common stock on the date of grant for any of the periods presented. The majority of the stock options issued under the 2005 Plan vest ratably over four-year periods and generally expire ten years from the date of grant. Restricted stock and time-based RSU awards issued under the 2005 Plan generally have restrictions that lapse ratably over periods ranging from one to four years however, up to 177,500 restricted stock awards may be issued with a vesting period of less than one year. Performance-based awards issued under the 2005 Plan generally vest based upon the achievement of pre-established performance goals over a specified three-year period. The number of shares of our common stock that may be earned in respect of performance-based awards may be greater or less than the target number of shares granted based on the actual performance achieved. The non-executive chairman of the Company’s Board of Directors is granted 6,000 shares of restricted stock on an annual bases and each non-employee director, other than the non-executive chairman, of the Company’s Board of Directors is granted 4,000 shares of restricted stock on an annual basis, in each case that will vest one year from the date of grant. The Company issues new shares of common stock upon exercise of vested stock options. As of November 3, 2018, there were 896,848 shares of the Company’s common stock available for grant under the 2005 Plan in the form of stock options, restricted stock, RSUs or deferred stock units.

Stock option activity for all plans was as follows:

	Outstanding Stock Options (in thousands)			Weighted Average Exercise Price		Weighted Average Remaining Life		Aggregate Intrinsic Value (in thousands)
Balance as of February 3, 2018	544			$	11.26
Granted	464			3.06
Exercised		—			—
Forfeited		(483	)	8.44
Expired		—			—
Balance as of November 3, 2018	525			$	6.62	8.4		$	598
Exercisable as of November 3, 2018	179			$	11.35		6.6		—

The following table summarizes information about stock options outstanding as of November 3, 2018:

	Stock Options Outstanding					Stock Options Exercisable
Range of Exercise Prices	Number Outstanding   (in thousands)	Weighted Average Remaining Life		Weighted Average Exercise Price		Number Exercisable (in thousands)		Weighted Average Exercise Price
$  2.65  to $  5.00	224		9.5	$	2.65		—	$	-
5.01  to   10.00	199		8.4		6.36	91			6.74
10.01  to   31.38	102		5.8		15.82	88			16.16
$  2.65  to  $31.38	525		8.4	$	6.62		179	$	11.35

The following table summarizes information about restricted stock and RSU activity for the 2005 Plan and includes 75,471 performance-based RSUs which is the number of RSUs that would be delivered if the target level of performance is achieved.  If performance was achieved at the maximum level, 150,942 RSUs would be delivered.  

	Outstanding Restricted Shares (in thousands)			Weighted Average Grant Date Fair Value
Unvested as of February 3, 2018		853		$	3.16
Granted		545			3.38
Vested		(144	)		3.81
Forfeited		(649	)		2.89
Unvested as of November 3, 2018		605		$	3.49

15

14. RECENT ACCOUNTING PRONOUNCEMENTS AND CHANGE IN ACCOUNTING PRINCIPLE

a. Newly Adopted Accounting Pronouncements

In May 2017 the Financial Accounting Standards Board (“FASB”) issued Accounting Standards Update (“ASU”) No. 2017-09, Compensation - Stock Compensation (Topic 718): Scope of Modification Accounting. ASU 2017-09 provides guidance about which changes to the terms or conditions of a share-based payment award require an entity to apply modification accounting in Topic 718. ASU No. 2017-09 is effective for financial statements issued for annual reporting periods beginning after December 15, 2017 and interim periods within those years. Earlier application is permitted. The Company adopted ASU No. 2017-09 effective February 4, 2018 and the adoption did not have a material impact on the Company’s consolidated financial position, results of operations or cash flows.

In October 2016 the FASB issued ASU No. 2016-16, Income Taxes (Topic 740): Intra-Entity Transfers of Assets Other Than Inventory. ASU No. 2016-16 amends the accounting for income taxes and requires the recognition of the income tax consequences of an intercompany asset transfer, other than transfers of inventory, when the transfer occurs. For intercompany transfers of inventory, the income tax effects will continue to be deferred until the inventory has been sold to a third party. ASU No. 2016-16 is effective for financial statements issued for annual reporting periods beginning after December 15, 2017 and interim periods within those years, using a modified retrospective application method through a cumulative-effect adjustment directly to retained earnings as of the beginning of the period of adoption. Earlier application is permitted. The Company adopted ASU No. 2016-16 effective February 4, 2018 and the adoption did not have a material impact on the Company’s consolidated financial position, results of operations or cash flows.

In August 2016 the FASB issued ASU No. 2016-15, Statement of Cash Flows (Topic 230): Classification of Certain Cash Receipts and Cash Payments. ASU No. 2016-15 clarifies and provides guidance on eight specific cash flow classification issues and is intended to reduce existing diversity in practice in how certain cash receipts and cash payments are presented and classified in the statement of cash flows. ASU No. 2016-15 is effective for annual reporting periods beginning after December 15, 2017 and interim periods within those years. Earlier application is permitted, provided that all of the amendments are adopted in the same period. The Company adopted ASU No. 2016-15 effective February 4, 2018 and the adoption did not have a material impact on the Company’s consolidated financial position, results of operations or cash flows.

In May 2014 the FASB issued ASU No. 2014-09, Revenue from Contracts with Customers (Topic 606). ASU No. 2014-09 requires an entity to recognize revenue for the amount of consideration to which it expects to be entitled for the transfer of promised goods or services to customers. Additionally, ASU No. 2014-09 requires improved disclosures to help users of financial statements better understand the nature, amount, timing, and uncertainty of revenue that is recognized. The standard replaced most existing revenue recognition guidance in GAAP when it became effective. ASU No. 2014-09 is effective for financial statements issued for annual reporting periods beginning after December 15, 2016 and interim periods within those years. In August 2015 the FASB issued ASU No. 2015-14, Revenue from Contracts with Customers (Topic 606): Deferral of the Effective Date which deferred the effective date of ASU No. 2014-09 by one year, making the guidance effective for fiscal years beginning after December 15, 2017.

Management adopted this guidance on February 3, 2018 using the modified retrospective approach.  This ASU required that sales return reserves be presented on a gross basis as a refund liability and an asset for recovery and that the asset be reported separate from inventory on the Company’s consolidated balance sheet.  Prior to the adoption of this ASU the Company had recorded its sales return reserve on a gross basis with the asset for recovery recorded as a component of inventory. The impact of adoption on the Company’s consolidated balance sheet as of November 3, 2018 is as follows:

						Excluding ASU
(in thousands)	As Reported		ASU 2014-09 Effect			2014-09 Effect
Inventories	$	79,054	$	(1,070	)		77,984
Prepaid expenses and other current assets		10,270		1,070			11,340

There was no impact from adoption on the Company’s consolidated statements of operations or consolidated statements of cash flow.  

b. Not Yet Adopted

In February 2016 the FASB issued ASU No. 2016-02, Leases (Topic 842). ASU No. 2016-02 affects any entity that enters into a lease (as that term is defined in the ASU) and its guidance supersedes Topic 840, Leases. As it substantively relates to the Company, ASU No. 2016-02 requires lessees to recognize a right-of-use asset and a lease liability, initially measured at the present value of the lease payments, in the statement of financial position. For finance leases, lessees are required to recognize interest on the lease liability

16

separately from amortization of the right-of-use asset in the statement of comprehensive income and to classify repayments of the principal portion of the lease liability within financing activities and payments of interest on the lease liability and variable lease payments within operating activities in the statement of cash flows. For operating leases, lessees are required to recognize a single lease cost, calculated so that the cost of the lease is allocated over the lease term on a generally straight-line basis, and to classify all cash payments within operating activities in the statement of cash flows. In transition, lessees are required to recognize and measure leases at the beginning of the earliest period presented using a modified retrospective approach. ASU No. 2016-02 is effective for financial statements issued for annual reporting periods beginning after December 15, 2018 and interim periods within those years. Earlier application is permitted. The Company has implemented its leasing software solution and is in the process of validating output. We are also evaluating the provisions of this standard including the finalization of the use of practical expedients and assessing our existing lease portfolio in order to determine the impact on our accounting systems, processes and internal controls over financial reporting.While the Company is still evaluating this standard, given the significant number of leases the Company is party to, the Company expects this standard will have a material impact on the Company's consolidated financial statements. The standard will have no impact on our debt-covenant compliance under our current agreements.

In August 2018, the FASB issued ASU 2018-15, Customer's Accounting for Implementation Costs Incurred in a Cloud Computing Arrangement that is a Service Contract. ASU 2018-15 requires implementation costs incurred by customers in cloud computing arrangements to be deferred over the non-cancellable term of the cloud computing arrangements plus any optional renewal periods (1) that are reasonably certain to be exercised by the customer or (2) for which exercise of the renewal option is controlled by the cloud service provider. The effective date of this pronouncement is for fiscal years beginning after December 15, 2019, and interim periods within those fiscal years, and early adoption is permitted. The standard can be adopted either using the prospective or retrospective transition approach. The Company is currently evaluating the impact of this pronouncement on the Company's consolidated financial statements and disclosures.

15. COMMITMENTS AND CONTINGENCIES

From time to time, the Company is named as a defendant in legal actions arising from normal business activities. Litigation is inherently unpredictable, and although the amount of any liability that could arise with respect to currently pending actions cannot be accurately predicted, the Company does not believe that the resolution of any pending action will have a material adverse effect on its financial position, results of operations or liquidity.

16. SEGMENT AND ENTERPRISE WIDE DISCLOSURES

Operating Segment. For purposes of the disclosure requirements for segments of a business enterprise, the Company has determined that its business is comprised of one operating segment: the design, manufacture and sale of maternity apparel and related accessories. While the Company offers a wide range of products for sale, the substantial portion of its products are initially distributed through the same distribution facilities, many of the Company’s products are manufactured at common contract manufacturer production facilities, the Company’s products are marketed through a common marketing department, and these products are sold to a similar customer base consisting of expectant mothers.

Geographic Information. Geographic revenue information is allocated based on the country in which the products or services are sold, and in the case of international franchise revenues, on the location of the customer. Information concerning the Company’s operations by geographic area was as follows (in thousands):

	Three Months Ended				Nine Months Ended
	November 3, 2018		October 28, 2017		November 3, 2018		October 28, 2017
Net Sales
United States	$	88,006	$	90,584	$	278,057	$	283,676
Foreign		4,831		5,770		14,402		17,384

	November 3, 2018		February 3, 2018
Long-Lived Assets
United States	$	54,696	$	65,456
Foreign		1,325		1,643

Major Customers. For the periods presented, the Company did not have any one customer who represented more than 10% of its net sales.

17

17. INTEREST EXPENSE, NET

Interest expense, net was comprised of the following (in thousands):

	Three Months Ended					Nine Months Ended
	November 3, 2018			October 28, 2017		November 3, 2018			October 28, 2017
Interest expense	$	1,233		$	1,006	$	3,535		$	2,991
Interest income		(1	)		-		(2	)		(2	)
Interest expense, net	$	1,232		$	1,006	$	3,533		$	2,989

18

Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations

We operate on a 52/53-week fiscal year ending on the Saturday nearest January 31 of each year. References in this discussion to our fiscal 2018 refer to the 52-week fiscal year, or periods within such fiscal year, which began February 4, 2018 and will end February 2, 2019. References to our fiscal 2017 refer to the 53-week fiscal year, or periods within such fiscal year, which began January 29, 2017 and ended February 3, 2018.

Forward-Looking Statements

Some of the information in this report, including the information incorporated by reference (as well as information included in oral statements or other written statements made or to be made by us), contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended (the “Exchange Act”). The forward-looking statements involve a number of risks and uncertainties. The following factors, among others, in some cases have affected, and in the future, could cause our actual results, performance, achievements or industry results to be materially different from any future results, performance or achievements expressed or implied by these forward-looking statements. These factors include, but are not limited to: the strength or weakness of the retail industry in general and of apparel purchases in particular, our ability to successfully manage our various business initiatives, the success of our international business and its expansion, our ability to successfully manage, retain and expand our leased department and international franchise relationships and marketing partnerships, future sales trends in our various sales channels, unusual weather patterns, changes in consumer spending patterns, raw material price increases, overall economic conditions and other factors affecting consumer confidence, demographics and other macroeconomic factors that may impact the level of spending for maternity apparel (such as fluctuations in pregnancy rates and birth rates), expense savings initiatives, our ability to anticipate and respond to fashion trends and consumer preferences, unanticipated fluctuations in our operating results, the impact of competition and fluctuations in the price, availability and quality of raw materials and contracted products, availability of suitable store locations, continued availability of capital through equity and debt financing, our ability to hire, develop and retain senior management and sales associates, our ability to develop and source merchandise, our ability to receive production from foreign sources on a timely basis, our compliance with applicable financial and other covenants under our financing arrangements, our ability to make potential debt prepayments and complete the new financing of the senior secured facility pursuant to the commitment letter with Bank of America,, the trading liquidity of our common stock, changes in market interest rates, our compliance with certain tax incentive and abatement programs, war or acts of terrorism and other factors referenced in our Annual Report on Form 10-K, including those set forth under the caption “Risk Factors.”

In addition, these forward-looking statements necessarily depend upon assumptions, estimates and dates that may be incorrect or imprecise and involve known and unknown risks, uncertainties and other factors. Accordingly, any forward-looking statements included in this report do not purport to be predictions of future events or circumstances and may not be realized. Forward-looking statements can be identified by, among other things, the use of forward-looking terms such as “believes,” “expects,” “may,” “will,” “should,” “seeks,” “pro forma,” “anticipates,” “intends,” “continues,” “could,” “estimates,” “plans,” “potential,” “predicts,” “goal,” “objective,” or the negative of any of these terms, or comparable terminology, or by discussions of our outlook, plans, goals, strategy or intentions. Forward-looking statements speak only as of the date made. Except as required by applicable law, including the securities laws of the United States and the rules and regulations of the SEC, we assume no obligation to update any of these forward-looking statements to reflect actual results, changes in assumptions or changes in other factors affecting these forward-looking statements.

Overview

We are the leading designer and retailer of maternity apparel in the United States with 1,108 retail locations, including 474 stores in the United States, Canada and Puerto Rico, and 634 leased departments located within department stores and baby specialty stores throughout North America. We also sell merchandise on the Internet, primarily through our Motherhood.com, APeaInThePod.com and Destinationmaternity.com websites. We also sell our merchandise through our Canadian website, MotherhoodCanada.ca, through Amazon.com in the United States, and through websites of certain of our retail partners, including Macys.com.  We have store franchise and product supply relationships in the Middle East, South Korea, Mexico, Israel and India. As of November 3, 2018, we have 187 international franchised locations, including 10 stand-alone stores operated under one of our retail nameplates and 177 shop-in-shop locations.

Refinancing

          On September 26, 2018, the Company entered into a commitment letter with Bank of America, pursuant to which, and subject to the terms and conditions set forth therein, Bank of America committed to provide to the Company certain five-year asset-based senior secured facilities consisting of an ABL with an aggregate commitment of $52 million and a FILO Term Loan with an aggregate principal amount of $24 million. The interest rates are expected to be, at the Company’s option, adjusted LIBOR or base rate plus an applicable margin based on excess availability. Such applicable margins for the base rate loans expect to range between 0.50% and 1.00% per annum in the case of the ABL and between 2.25% and 2.75% per annum in the case of the FILO Term Loan. Such applicable margins for the LIBOR loans expect to range between 1.5% to 2.0% in the case of the ABL and between 3.25% to 3.75% in

19

the case of the FILO Term Loan. The funding of the senior secured facilities under the commitment letter is contingent upon the satisfaction of customary conditions, including, but not limited to, the parties’ entering into definitive documentation, absence of material adverse events or conditions with respect to the Company and the receipt of payoff letters in respect of the Company’s existing credit agreements governing its outstanding indebtedness. It is anticipated that the Company will use the net proceeds of the senior secured facilities to repay outstanding indebtedness under its existing term loan and revolving credit facility.  The Company is currently in discussions with Bank of America regarding amendments to the commitment letter, including an extension of the expiration date.

Proxy Solicitation

In the first quarter of fiscal 2018 we received notification from a stockholder group (“the Stockholder Group”), of the nomination of a slate of alternative nominees for election to our Board of Directors at the Annual Meeting of Stockholders that was held on May 23, 2018 (the “Proxy Solicitation”). At our 2018 Annual Meeting of Stockholders held on May 23, 2018, the Company’s stockholders replaced the incumbent board in its entirety and elected Holly N. Alden, Christopher B. Morgan, Marla A. Ryan and Anne-Charlotte Windal as our new Board of Directors. During the nine months ended November 3, 2018 we incurred $2.2 million of charges related to the Proxy Solicitation.

Proposed Merger

On December 19, 2016 we entered into the Merger Agreement with Orchestra. Despite substantial and sustained efforts by both parties, and in light of the challenges of satisfying applicable securities regulations in France and in the United States, particularly in connection with the completion of the registration and listing of Orchestra securities in the United States, the parties determined that it was in the best interests of their respective stockholders to terminate the Merger Agreement. Accordingly, on July 27, 2017 we, Orchestra, and certain other affiliates of Orchestra entered into a Termination Agreement pursuant to which the parties agreed to terminate the Merger Agreement. We and Orchestra agreed to reimburse each other for certain costs incurred in connection with their effort to implement the Merger Agreement, with a net amount of $1.0 million paid to us on July 31, 2017. During the nine months ended October 28, 2017 we recognized $1.1 million of charges related to the Termination of Merger.

Management and Organizational Changes

We have engaged in a series of management and organizational changes over the last several years. Through these actions, we are attempting to identify further opportunities to become more profitable in the near future, by increasing both revenue and gross margins while reducing expenses.

During the nine months ended November 3, 2018 and October 28, 2017 we recognized $2.7 million and $2.6 million, respectively, of charges related to management and organizational changes.

Change in Accounting Principle

During the first quarter of fiscal 2017, we changed the way we account for recording revenue from gift cards sold to retail customers that were never redeemed, commonly referred to as breakage. We determined that this accounting change represents a change in accounting estimate effected by a change in accounting principle. In accordance with the requirements of ASC Topic 250 related to such accounting changes, during the first quarter of fiscal 2017 we recognized $0.8 million of revenue as a cumulative adjustment for the accounting change.

Presentation of Financial Information

Comparable sales figures represent sales at retail locations (which does not include licensed brand or international franchise relationships) that have been in operation by us for at least 13 full months, as well as Internet sales. Our comparable sales figures generally do not include: 1) retail locations which change location type or format, 2) retail locations which are expanded, contracted or relocated if the square footage of the retail location has changed by 20% or more, or, if in the judgment of management, such expansion, contraction or relocation materially alters the comparability of the retail location (either with respect to the manner of its operation or otherwise), 3) in the case of relocations only, retail locations which are not in the same immediate geographical vicinity (such as, without limitation, the same mall, the same part of a mall, or the same street) after the relocation, 4) retail locations that have temporarily closed for any reason for 30 days or more, or 5) retail locations which, in the judgment of management, have undergone other significant changes which materially alter the comparability of the retail location (either with respect to the manner of its operation or otherwise) (such as, for example only, in the case of closure of retail locations in connection with the cessation of a leased department relationship where the manner of operation of such retail location has been materially altered prior to closure, or in the case of construction in, on or near a retail location, which significantly interferes with the customer traffic, visibility or operation of a retail location). Comparable sales exclude the 53^rd week of sales for 53-week fiscal years. In the 52-week fiscal year subsequent to a 53-week fiscal year, we exclude the sales in the non-comparable week from the comparable sales calculation. There may be variations

20

in the way in which other retailers calculate comparable sales. As a result, data in this quarterly report regarding our comparable sales may not be comparable to similar data made available by other retailers.

Presented below is a summary of our results for the third quarter and first nine months of fiscal 2018 with regard to each of the key measures noted below:

Use of Non-GAAP Measures

In assessing the performance of our business, we consider a variety of operational and financial measures. The key measures for determining how our business is performing are net income (loss) determined in accordance with GAAP (“net income (loss)”) and the corresponding net income (loss), (or earnings (loss)) per share (diluted), net income (loss) before certain charges or credits, when applicable, such as other charges, loss on extinguishment of debt, and certain infrequent income tax adjustments (“adjusted net income (loss)”) and the corresponding earnings (loss) per share (diluted), Adjusted EBITDA (defined below), Adjusted EBITDA before other charges, net sales, and comparable sales. Adjusted EBITDA represents operating income (loss) before deduction for the following non-cash charges: 1) depreciation and amortization expense, 2) loss on impairment of tangible and intangible assets, 3) loss on disposal of assets, and 4) stock-based compensation expense.

Our management believes that each of the non-GAAP financial measures presented by us provides useful information about our results of operations and/or financial position to both investors and management. Each non-GAAP financial measure is provided because management believes it is an important measure of financial performance used in the retail industry to measure operating results, to determine the value of companies within the industry and to define standards for borrowing from institutional lenders. We use each of these non-GAAP financial measures as a measure of our performance. In addition, certain of our cash and equity incentive compensation plans are based on our level of achievement of Adjusted EBITDA before other charges, which is substantially identical to our non-GAAP financial measure of Adjusted EBITDA before certain other deductions.

We provide these various non-GAAP financial measures to investors to assist them in performing their analysis of our historical operating results. Each of these non-GAAP financial measures reflects a measure of our operating results before consideration of certain charges and consequently, none of these measures should be construed as an alternative to net income (loss) or operating income (loss) as an indicator of our operating performance, or as an alternative to cash flows from operating activities as a measure of our liquidity, as determined in accordance with GAAP. We may calculate each of these non-GAAP financial measures differently than other companies.

With respect to the non-GAAP financial measures discussed in Management’s Discussion and Analysis of Financial Condition and Results of Operations, we have provided reconciliations of the non-GAAP financial measures to the most directly comparable GAAP financial measures in this Quarterly Report.

Third Quarter Fiscal 2018 Financial Results

• Net loss for the third quarter of fiscal 2018 was $4.1 million, or $0.30 per share (diluted), compared to net loss of $7.5 million, or $0.55 per share (diluted), for the third quarter of fiscal 2017.

• Net loss for the third quarter of fiscal 2018 includes a $1.4 million, net of tax, charge related to the Proxy Solicitation and management and organizational changes and a $1.0 million, non-cash income tax charge related to the change in valuation allowance against net deferred tax assets.  Net loss for the third quarter of fiscal 2017 includes a $1.9 million, net of tax charge related to the Proposed Merger and management and organizational changes and a $2.9 million, non-cash income tax charge related to a change in the valuation allowance against net deferred tax assets.

• Adjusted net loss for the third quarter of fiscal 2018 was $1.7 million, or $0.12 per share (diluted), compared to the comparably adjusted net loss for the third quarter of fiscal 2017 of $2.7 million, or $0.20 per share (diluted).

• Adjusted EBITDA was $2.1 million for the third quarter of fiscal 2018, compared to $(1.1) million of Adjusted EBITDA for the third quarter of fiscal 2017.

• Adjusted EBITDA before other charges was $3.9 million for the third quarter of fiscal 2018, an increase of 95% compared to $2.0 million of Adjusted EBITDA before other charges for the third quarter of fiscal 2017.

• Net sales for the third quarter of fiscal 2018 decreased 3.7% to $92.8 million from $96.4 million for the third quarter of fiscal 2017.

• Comparable sales for the third quarter of fiscal 2018 decreased 2.6% compared to a comparable sales increase of 1.1% for the third quarter of fiscal 2017.

21

First Nine Months of Fiscal 2018 Financial Results

• Net loss for the first nine months of fiscal 2018 was $7.9 million, or $0.57 per share (diluted), compared to a net loss of $11.4 million, or $0.83 per share (diluted), for the first nine months of fiscal 2017.

• Net loss for the first nine months of fiscal 2018 includes a $3.7 million, net of tax, charge related to Proxy Solicitation and management and organizational changes and a $1.9 million, non-cash income tax charge related to a change in the valuation allowance against net deferred tax assets. Net loss for the first nine months of fiscal 2017 includes $2.3 million, net of tax, related to the Proposed Merger and management and organizational changes, revenue of $0.5 million, net of tax, related to a cumulative adjustment for a change in accounting principle, and a $4.4 million, non-cash income tax charge related to a change in the valuation allowance against net deferred tax assets.

• Adjusted net loss for the first nine months of fiscal 2018 was $2.3 million, or $0.16 per share (diluted), compared to the comparably adjusted net loss for the first nine months of fiscal 2017 of $5.2 million, or $0.38 per share (diluted).

• Adjusted EBITDA was $10.8 million for the first nine months of fiscal 2018, an increase of 13.8% compared to $9.5 million of Adjusted EBITDA for the first nine months of fiscal 2017.

• Adjusted EBITDA before other charges and effect of change in accounting principle was $15.7 million for the first nine months of fiscal 2018, an increase of 25.9% compared to $12.5 million of Adjusted EBITDA before other charges for the first nine months of fiscal 2017.

• Net sales for the first nine months of fiscal 2018 decreased 2.9% to 292.5 million from $301.1 million for the first nine months of fiscal 2017.

• Comparable sales for the first nine months of fiscal 2018 decreased 0.5% compared to a comparable sales decrease of 3.5% for the first nine months of fiscal 2017.

Results of Operations

The following table sets forth certain operating data as a percentage of net sales and as a percentage change for the three and nine months ended November 3, 2018 and October 28, 2017:

	% of Net Sales (1)												% Change Period to Period Favorable (Unfavorable)
	Three Months Ended						Nine Months Ended						Three Months Ended November 3, 2018 vs.			Nine Months Ended November 3, 2018 vs.
	November 3, 2018			October 28, 2017			November 3, 2018			October 28, 2017			October 28, 2017			October 28, 2017
Net sales		100.0	%		100.0	%		100.0	%		100.0	%		(3.7	)%		(2.9	)%
Cost of goods sold (2)		47.6			47.2			47.4			46.6			2.8			1.2
Gross profit		52.4			52.8			52.6			53.4			(4.4	)		(4.3	)
Selling, general and administrative expenses (3)		52.4			55.2			51.5			53.7			8.7			6.9
Store closing, asset impairment and asset disposal    expenses		1.1			1.0			0.9			1.2			(1.7	)		26.9
Other charges, net		2.0			3.2			1.7			1.2			(41.1	)		(30.8	)
Operating loss		(3.0	)		(6.7	)		(1.4	)		(2.7	)		56.1			48.4
Interest expense, net		1.3			1.0			1.2			1.0			(22.5	)		(18.2	)
Loss before income taxes		(4.4	)		(7.7	)		(2.7	)		(3.7	)		45.5			30.6
Income tax provision		0.1			0.1			0.1			0.1			23.3			35.1
Net loss		(4.4	)%		(7.8	)%		(2.7	)%		(3.8	)%		45.3	%		30.7	%

(1) Components may not add to the exact total amount due to rounding.

(2) “Cost of goods sold” includes merchandise costs (including customs duty expenses), expenses related to inventory shrinkage, product related corporate expenses (including expenses related to our payroll, benefit costs and operating expenses of our buying departments), inventory reserves (including lower of cost or net realizable value reserves), inbound freight charges, purchasing and receiving costs, inspection costs, distribution center costs (including occupancy expenses and equipment depreciation), internal transfer costs, and the other costs of our distribution network, partially offset by the allocable amount of our Grow NJ benefit.

22

(3) “Selling, general and administrative expenses” includes advertising and marketing expenses, corporate administrative expenses, corporate headquarters occupancy expenses, store expenses (including store payroll and store occupancy expenses), and store opening expenses, partially offset by the allocable amount of our Grow NJ benefit.

The following tables set forth certain information concerning the number of our retail locations and international franchised locations for the periods indicated.

	Three Months Ended
	November 3, 2018									October 28, 2017
Retail Locations (1)	Stores			Leased Departments			Total Retail Locations			Stores			Leased Departments			Total Retail Locations
Beginning of period		480			634			1,114			507			643			1,150
Opened		—			1			1			2			4			6
Closed		(6	)		(1	)		(7	)		(8	)		(1	)		(9	)
End of period		474			634			1,108			501			646			1,147

	Nine Months Ended
	November 3, 2018									October 28, 2017
Retail Locations (1)	Stores			Leased Departments			Total Retail Locations			Stores			Leased Departments			Total Retail Locations
Beginning of period		487			637			1,124			515			705			1,220
Opened		2			2			4			7			6			13
Closed (2)		(15	)		(5	)		(20	)		(21	)		(65	)		(86	)
End of period		474			634			1,108			501			646			1,147

(1) Includes Macy’s completed closure of 59 stores where we had a leased department within the store during the nine months ended October 28, 2017.

	Three Months Ended
	November 3, 2018								October 28, 2017
International Franchised Locations	Stores			Shop-in- Shop Locations		Total International Franchised Locations			Stores			Shop-in- Shop Locations		Total International Franchised Locations
Beginning of period		11			177		188			18			192		210
Opened		—			—		-			—			—		—
Closed		(1	)		—		(1	)		(2	)		-		(2	)
End of period		10			177		187			16			192		208

	Nine Months Ended
	November 3, 2018									October 28, 2017
International Franchised Locations	Stores			Shop-in- Shop Locations			Total International Franchised Locations			Stores			Shop-in- Shop Locations			Total International Franchised Locations
Beginning of period		15			173			188			19			194			213
Opened		—			6			6			—			8			8
Closed		(5	)		(2	)		(7	)		(3	)		(10	)		(13	)
End of period		10			177			187			16			192			208

Three Months Ended November 3, 2018 and October 28, 2017

Net Sales.    Our net sales for the third quarter of fiscal 2018 decreased by 3.7%, or $3.6 million, to $92.8 million from $96.4 million for the third quarter of fiscal 2017. Comparable sales for the third quarter of fiscal 2018 decreased 2.6% compared to a comparable sales increase of 1.1% for the third quarter of fiscal 2017. The decrease in total reported sales for the third quarter of fiscal

23

2018 compared to the third quarter of fiscal 2017 resulted primarily from the closure of underperforming retail locations and decline in comparable store sales.

Gross Profit.    Our gross profit for the third quarter of fiscal 2018 decreased by 4.4%, or approximately $2.2 million, to $48.7 million from $50.9 million for the third quarter of fiscal 2017, and our gross profit as a percentage of net sales (gross margin) for the third quarter of fiscal 2018 was 52.4% compared to 52.8% for the third quarter of fiscal 2017. The decrease in gross profit for the third quarter of fiscal 2018 compared to the third quarter of fiscal 2017 was primarily due to our lower sales volume as a result of the closure of underperforming retail locations and decline in comparable store sales. The year-over-year decrease in gross margin is primarily a result of increased markdown and promotional activity to more aggressively manage inventory in addition to the increase in ecommerce sales as a portion of our total retail sales.

Selling, General and Administrative Expenses.    Our selling, general and administrative expenses for the third quarter of fiscal 2018 decreased by 8.7%, or $4.6 million, to $48.6 million from $53.2 million for the third quarter of fiscal 2017. As a percentage of net sales, selling, general and administrative expenses decreased to 52.4% for the third quarter of fiscal 2018 from 55.2% for the third quarter of fiscal 2017. This decrease in expense for the quarter primarily reflects reductions in employee costs and occupancy expenses resulting from the closure of underperforming stores and ongoing expense reduction initiatives.

Store Closing, Asset Impairment and Asset Disposal Expenses.   Our store closing, asset impairment and asset disposal expenses was $1.0 million for both the third quarter of fiscal 2018 and fiscal 2017.

Other Charges, Net.    In the third quarter of fiscal 2018 we incurred other charges of $1.8 million which is primarily personnel costs and consulting fees related to our management and organizational change initiatives. In the third quarter of fiscal 2017 we incurred other charges of $3.1 million of which $0.5 million related to the Proposed Merger and $2.6 million in personnel costs and consulting fees related to our management and organizational change initiatives.

Operating Loss.    We had an operating loss of $2.8 million for the third quarter of fiscal 2018 compared to an operating loss of $6.4 million for the third quarter of fiscal 2017. The $3.6 million decrease in operating loss reflects a $2.2 million reduction in gross margin offset by a $4.6 million decrease in selling, general and administrative expenses and a $1.3 million decrease in other charges.

Interest Expense, Net.    Net interest expense of $1.2 million for the third quarter of fiscal 2018 was $0.2 million higher than the third quarter of fiscal 2017. This increase is the result of an increase in both interest rates and our average debt outstanding.

Income Tax Provision.    For the third quarter of fiscal 2018 and fiscal 2017 our income tax provision was $56,000 and $73,000, respectively.  These tax provisions primarily represent minimum state income taxes.  Since fiscal 2016 we have been recording valuation allowances to reduce deferred tax assets, primarily net operating loss carryforwards.  In the third quarter of fiscal 2018 we recorded a non-cash charge of $1.0 million to increase our deferred tax asset valuation allowance.

Net Loss.    Net loss for the third quarter of fiscal 2018 was $4.1 million, or $0.30 per share (diluted), compared to net loss of $7.5 million, or $0.55 per share (diluted), for the third quarter of fiscal 2017. Net loss for the third quarter of fiscal 2018 includes a $1.0 million non-cash income tax charge related to a change in the valuation allowance against net deferred tax assets and other charges of $1.4 million, net of tax, related to the Proxy Solicitation and management and organizational changes. Net loss for the third quarter of fiscal 2017 includes a $2.9 million non-cash income tax charge related to a change in the valuation allowance against deferred tax assets and other charges of $1.9 million, net of tax, related to the Proposed Merger and management and organizational change.

Our average diluted shares outstanding of 13.9 million was comparable to the 13.8 million average diluted shares for the third quarter of fiscal 2017.

24

The following is a reconciliation of net loss and net loss per share (diluted) (“Diluted EPS”) to adjusted net loss and adjusted Diluted EPS for the three months ended November 3, 2018 and October 28, 2017 (in thousands, except per share amounts):

	Three Months Ended
	November 3, 2018								October 28, 2017
	Net Loss			Diluted Shares		Diluted EPS			Net Loss			Diluted Shares		Diluted EPS
As reported	$	(4,114	)		13,895	$	(0.30	)	$	(7,523	)		13,800	$	(0.55	)
Other charges		1,825			—					3,100			—
Income tax effect of other charges (1)		(444	)		—					(1,163	)		—
Deferred tax valuation allowance related to    cumulative losses		1,001			—					2,855			—
As adjusted	$	(1,732	)		13,895	$	(0.12	)	$	(2,731	)		13,800	$	(0.20	)

(1) Income tax effect of other charges represents the differences in income tax provision calculated with and without the specified items of pretax expense or (income).

The following is a reconciliation of net loss to Adjusted EBITDA and Adjusted EBITDA before other charges for the third quarter of fiscal 2018 and 2017 (in thousands):

	Three Months Ended
	November 3, 2018			October 28, 2017
Net loss	$	(4,114	)	$	(7,523	)
Add: income tax provision		56			73
Add: interest expense, net		1,232			1,006
Operating loss		(2,826	)		(6,444	)
Add: depreciation and amortization expense		3,828			4,371
Add: loss on impairment of long-lived assets		717			821
Add: loss on disposal of assets		170			167
Add: stock-based compensation expense		166			28
Adjusted EBITDA		2,055			(1,057	)
Add: other charges		1,825			3,100
Adjusted EBITDA before other charges	$	3,880		$	2,043

Nine Months Ended November 3, 2018 and October 28, 2017

Net Sales.    Our net sales for the nine months of fiscal 2018 decreased by 2.9%, or $8.6 million, to $292.5 million from $301.1 million for the first nine months of fiscal 2017. Comparable sales for the first nine months of fiscal 2018 decreased 0.5% compared to a comparable sales decrease of 3.5% for the first nine months of fiscal 2017. Fiscal 2018 comparable store sales reflects an increase in ecommerce sales of 18.1% partially offset by a decrease in brick and mortar comparable store sales of 5.4%. The decrease in total reported sales for the first nine months of fiscal 2018 compared to the first nine months of fiscal 2017 resulted primarily from a decrease in brick and mortar comparable store sales, the closure of underperforming stores, a decrease in sales to wholesale and franchise partners and the recognition of $0.8 million of revenue related to the change in our method of accounting for gift card breakage in the first quarter of fiscal 2017.

Gross Profit.    Our gross profit for the first nine months of fiscal 2018 decreased by 4.3%, or $7.0 million, to $153.9 million from $160.9 million for the first nine months of fiscal 2017, and our gross margin for the first nine months of fiscal 2018 was 52.6% compared to 53.4% for the first nine months of fiscal 2017. The decrease in gross profit for the first nine months of fiscal 2018 compared to the first nine months of fiscal 2017 was primarily due to our lower sales volume as a result of the factors discussed above. The year-over-year decrease in gross margin is the result of the increase in ecommerce sales as a portion of our total retail sales.

25

Selling, General and Administrative Expenses.    Our selling, general and administrative expenses for the first nine months of fiscal 2018 decreased by 6.9%, or $11.1 million, to $150.6 million from $161.7 million for the first nine months of fiscal 2017. As a percentage of net sales, selling, general and administrative expenses decreased to 51.5% for the first nine months of fiscal 2018 from 53.7% for the first nine months of fiscal 2017.  The decrease in expense for the first nine months of fiscal 2018 primarily reflects reductions in employee costs and occupancy expenses resulting from the closure of underperforming stores and ongoing expense reduction initiatives.  

Store Closing, Asset Impairment and Asset Disposal Expenses.     Our store closing, asset impairment and asset disposal expenses for the first nine months of fiscal 2018 decreased by $0.9 million, to $2.7 million from $3.6 million for the first nine months of fiscal 2017, reflecting lower impairment charges for write-downs of long-lived assets.

Other Charges, Net.    In the first nine months of fiscal 2018 we incurred other charges of $4.9 million, $2.2 million related to the Proxy Solicitation and $2.7 million related to management and organizational changes. In the first nine months of fiscal 2017 we incurred other charges of $3.7 million including $1.1 million related to the Proposed Merger and $2.6 million related to management and organizational changes.

Operating Loss.    We had an operating loss of $4.2 million for the first nine months of fiscal 2018 compared to an operating loss of $8.2 million for the first nine months of fiscal 2017. The approximately $4.0 million decrease in operating loss reflects the $11.1 million reduction in selling, general and administrative expenses partially offset by our lower gross profit as a result of the decline in sales volume.

Interest Expense, Net.    Our net interest expense for the first nine months of fiscal 2018 increased to $3.5 million from $3.0 million for the first nine months of fiscal 2017. This increase was due to our higher effective borrowing rate and increases in our average debt outstanding.

Income Tax Provision.    For the first nine months of fiscal 2018 our income tax provision was $168,000. In the first nine months of fiscal 2018 we recorded a non-cash charge of $1.9 million to increase the valuation allowance against substantially all of our deferred tax assets. Excluding the effect of the valuation allowance charge, our effective tax benefit rate for the first nine months of fiscal 2018 was 24.3%. This rate is slightly higher than the statutory federal tax rate of 21% due to state income tax benefits, net of federal expense, offset by certain state minimum income taxes and the impact from recognizing tax deficiencies from share-based payment awards as income tax expense rather than in additional paid-in capital, as required by the adoption of ASU No. 2016-09. For the first nine months of fiscal 2017 our effective tax rate was 36.6%. Our effective tax rate was higher than the statutory federal tax rate of 35% primarily due to state income tax benefits, net of federal expense.

Net Loss.    Net loss for the first nine months of fiscal 2018 was $7.9 million, or $0.57 per share (diluted), compared to a net loss of $11.4 million, or $0.83 per share (diluted), for the first nine months of fiscal 2017. Net loss for the first nine months of fiscal 2018 includes other charges of $3.7 million, net of tax related to the Proxy Solicitation and organizational changes and a $1.9 million non-cash income-tax charge related to a change in the valuation allowance against net deferred tax assets. Net loss for the first nine months of fiscal 2017 includes a $4.4 million non-cash income tax charge related to a change in the valuation allowance against net deferred tax assets, revenue of $0.5 million, net of tax, related to a cumulative adjustment for the effect of a change in accounting principle, and other charges of $2.3 million, net of tax, related to the Proposed Merger and management and organizational changes.

Our average diluted shares outstanding of 13.9 million as of the first nine months of fiscal 2018 were comparable to the 13.8 million average diluted shares for the first nine months of fiscal 2017.

26

The following is a reconciliation of net loss and Diluted EPS to adjusted net income (loss) and adjusted Diluted EPS for the nine months ended November 3, 2018 and October 28, 2017 (in thousands, except per share amounts):

	Nine Months Ended
	November 3, 2018								October 28, 2017
	Net Loss			Diluted Shares		Diluted EPS			Net Income			Diluted Shares		Diluted EPS
As reported	$	(7,925	)	$	13,867	$	(0.57	)	$	(11,439	)		13,771	$	(0.83	)
Other charges		4,898			—					3,746			—
Income tax effect of other charges (1)		(1,190	)		—					(1,405	)		—
Effect of change in accounting principle		—			—					(764	)		—
Income tax effect of change in accounting    principle (1)		—			—					284			—
Deferred tax valuation allowance related to    cumulative losses		1,925			—					4,352			—
As adjusted	$	(2,292	)		13,867	$	(0.17	)	$	(5,226	)		13,771	$	(0.38	)

(1) Income tax effect of other charges and change in accounting principle represents the differences in income tax provision calculated with and without specified items of pretax expense or (income).

The following is a reconciliation of net income (loss) to Adjusted EBITDA and Adjusted EBITDA before other charges and effect of change in accounting principle for the nine months ended November 3, 2018 and October 28, 2017 (in thousands):

	Nine Months Ended
	November 3, 2018			October 28, 2017
Net income	$	(7,925	)	$	(11,439	)
Add: income tax provision		168			259
Add: interest expense, net		3,533			2,989
Operating income (loss)		(4,224	)		(8,191	)
Add: depreciation and amortization expense		11,788			13,259
Add: loss on impairment of long-lived assets		2,236			3,267
Add: loss on disposal of assets		238			283
Add: stock-based compensation expense		750			858
Adjusted EBITDA		10,788			9,476
Add: other charges		4,898			3,746
Less: effect of change in accounting principle		—			(764	)
Adjusted EBITDA before other charges and effect of    change in accounting principle	$	15,686		$	12,458

Seasonality

Our business, like that of many other retailers, is seasonal. Our quarterly net sales have historically been highest in the peak Spring selling season, which will generally occur during the calendar months of March through May, in our first fiscal quarter and the early part of our third fiscal quarter. Given the typically higher sales level in that timeframe and the relatively fixed nature of most of our operating expenses, we have historically generated a significant percentage of our full year operating income during this period. Results for any quarter are not necessarily indicative of the results that may be achieved for a full fiscal year. Quarterly results may be subject to substantial fluctuation depending upon, among other things, increases or decreases in comparable sales, the timing of new store openings and closings, new leased department openings and closings, net sales and profitability contributed by new stores and leased departments, the timing of the fulfillment of purchase orders under our product and license arrangements, adverse weather conditions, shifts in the timing of certain holidays and promotions, changes in inventory and production levels and the timing of deliveries of inventory, and changes in our merchandise mix.

27

Liquidity and Capital Resources

Our cash needs have primarily been for 1) capital expenditures, including (i) leasehold improvements, fixtures and equipment for new stores, store relocations and remodels of our existing stores, and (ii) investment in information systems and technology, 2) debt service, including principal prepayments, and 3) working capital, including inventory to support our business. We have historically financed our capital requirements from cash flows from operations, borrowings under our credit facilities or available cash balances.

Cash and cash equivalents decreased by $0.4 million during the first nine months of fiscal 2018 compared to a decrease of $0.6 million for the first nine months of fiscal 2017.

Cash used in operations was $7.4 million for the first nine months of fiscal 2018 as compared to $7.1 million of cash provided by operations for the first nine months of fiscal 2017. This decrease of approximately $14.5 million in cash provided by operations compared to the prior period is primarily the result of the expected non-recurrence of receipt of a $4.5 million federal income tax refund and the receipt of $3.3 million cash proceeds from the sale of our fiscal 2016 Grow NJ tax credits in the first nine months of fiscal 2017 and a $9.3 million increase in the net investment in inventory (inventory less accounts payable) in fiscal 2018 compared to fiscal 2017, partially offset by a $3.5 million reduction in our net loss.  Our working capital changes, quarterly net income (loss) and cash flow adjustments may fluctuate significantly, and net cash provided by or used in operating activities for any interim period is not necessarily indicative of the results that may be achieved for a full fiscal year.

During the first nine months of fiscal 2018, we borrowed $13.7 million against our line of credit to provide working capital, make periodic payments on our equipment loans and fund capital expenditures. Capital expenditures for the first nine months of fiscal 2018 totaled $3.5 million, including $2.3 million for improvements to new and existing stores and $1.2 million for information systems.  We expect to use borrowings under our existing $50.0 million senior secured revolving credit facility to fund a portion of our capital requirements from time to time during the remainder of our 2018 fiscal year.  

On February 1, 2018 (the “Closing Date”) we entered into a Term Loan Credit Agreement (the “Term Loan Agreement”) which provides for a term loan of up to $25.0 million (the “Term Loan”).  On the Closing Date we borrowed $22.5 million against the Term Loan and used the proceeds, in addition to $3.6 million borrowed under our Credit Facility to repay the balance of our then existing term loan and fees relating to the Term Loan Agreement financing.  

In July 2018, we borrowed an additional $2.5 million under our Term Loan increasing the balance to $25.0 million, the full amount permitted to be outstanding under the agreement. During the first nine months of fiscal 2017, $3.4 million of proceeds from an equipment financing transaction were used to prepay a portion of our Prior Term Loan.

The Term Loan matures on January 31, 2023 (the “Maturity Date”).  There is a minimum excess availability requirement of the greater of 10% of the combined loan cap, as defined in the Term Loan Agreement, or $7.0 million. The interest rate on the Term Loan is equal to a LIBOR rate plus 9.0%.  We are required to make minimum payments of $0.3 million each quarter commencing on July 31, 2018, with the remaining outstanding balance payable on the Maturity Date.  The Term Loan can be prepaid at our option, subject to certain restrictions and subject to a prepayment premium as follows: 1) if prepayment occurs on or prior to the third anniversary of the Closing Date, the greater of a) interest on the prepayment that would otherwise have been paid with the 24 month period following the Closing Date minus actual interest payments made through the prepayment date and b) 2% of the prepayment, and 2) 2% of the prepayment amount if paid between the third and third anniversary of the Closing Date.      

In conjunction with entering into the Term Loan Agreement, on February 1, 2018 we also amended and restated our credit facility (the “Credit Facility”).  This amendment, among other things, reduced the borrowing amount under the Credit Facility from $70.0 million to $50.0 million, extended the Termination Date to January 31, 2023 and reduced or eliminated certain availability reserves.  

On September 26, 2018, the Company entered into a commitment letter with Bank of America, pursuant to which, and subject to the terms and conditions set forth therein, Bank of America committed to provide to the Company certain five-year asset-based senior secured facilities consisting of an ABL with an aggregate commitment of $52 million and a FILO Term Loan with an aggregate principal amount of $24 million. The interest rates are expected to be, at the Company’s option, adjusted LIBOR or base rate plus an applicable margin based on excess availability. Such applicable margins for the base rate loans expect to range between 0.50% and 1.00% per annum in the case of the ABL and between 2.25% and 2.75% per annum in the case of the FILO Term Loan. Such applicable margins for the LIBOR loans expect to range between 1.5% to 2.0% in the case of the ABL and between 3.25% to 3.75% in the case of the FILO Term Loan. The funding of the senior secured facilities under the commitment letter is contingent upon the satisfaction of customary conditions, including, but not limited to, the parties’ entering into definitive documentation, absence of material adverse events or conditions with respect to the Company and the receipt of payoff letters in respect of the Company’s existing credit agreements governing its outstanding indebtedness. It is anticipated that the Company will use the net proceeds of the

28

senior secured facilities to repay outstanding indebtedness under its existing term loan and revolving credit facility.  The Company is currently in discussions with Bank of America regarding amendments to the commitment letter, including an extension of the expiration date.

On March 25, 2016 we entered into a Term Loan Credit Agreement (the “Prior Term Loan Agreement”) for a $32.0 million term loan due March 25, 2021 (the “Prior Term Loan”). The interest rate on the Prior Term Loan was equal to a LIBOR rate (with a 1.00% LIBOR floor) plus 7.50%. We were required to make minimum repayments of the principal amount in quarterly installments of $0.8 million each, with the remaining outstanding balance payable on the maturity date. The Prior Term Loan had a prepayment option, subject to the payment of a prepayment premium, that we exercised on the Closing Date.  We paid a prepayment premium of $0.2 million, or 2% of the then outstanding loan balance. There were various minimum excess availability requirements applicable to the Prior Term Loan including $5.0 million against availability under our Credit Facility that will be reduced dollar for dollar for prepayments of the Prior Term Loan, an amount equal to the greater of 10% of the Combined Loan Cap (as defined in the Prior Term Loan Agreement) or $10.0 million and a $10.0 million EBITDA as defined in the Prior Term Loan Agreement.

As of November 3, 2018, we had $21.7 million in borrowings and $7.3 million in letters of credit outstanding under the Credit Facility with $13.5 million of availability. As of October 28, 2017, we had $8.2 million of borrowings and $7.3 million in letters of credit with $12.5 million of availability. For the first nine months of fiscal 2018 our borrowings had a weighted interest rate of 4.11% per annum, our average level of borrowing was $17.3 million and our maximum borrowing at any time was $27.4 million.  For the first nine months of fiscal 2017 our borrowings had a weighted interest rate of 3.51% per annum our average level of direct borrowings was $8.7 million and our maximum borrowings at any time were $15.7 million.

As of November 3, 2018, and October 28, 2017, there was $3.7 million and $7.1 million, respectively, outstanding under a five-year equipment financing arrangement with our Credit Facility lender. The equipment note bears annual interest at 3.38%, with payments of $0.3 million (including interest) due monthly through December 2019. The equipment note is collateralized by substantially all of the material handling equipment at our distribution facility in Florence, New Jersey.

On June 6, 2017 we received $3.4 million in proceeds from a three-year financing arrangement in the form of a sale and leaseback for certain furniture, fixtures and software.  Monthly payments under the leaseback arrangement are $0.1 million for the first 24 months and $48,000 for months 25 to 36.  At the end of the leaseback term, we have the option to extend the financing for an additional year or repurchase the property for a price to be agreed upon. All proceeds from the transaction were used to prepay a portion of our Term Loan.  As of November 3, 2018, there was $1.7 million of principal outstanding under the arrangement.

In connection with the relocation of our corporate headquarters and our distribution operations from Philadelphia, Pennsylvania to southern New Jersey, the Board of the NJEDA approved us for an incentive package of up to $4.0 million in annual benefits under Grow NJ in the form of transferrable income tax credits over a ten-year period from the State of New Jersey. The annual benefit amount available to us is based on an average of eligible jobs within the state and is expected to significantly exceed our annual income tax liability to New Jersey. In order to maximize the realizable value of our incentive package we have an agreement with a third party to sell 75% or more of the annual income tax credits awarded to us. For fiscal 2017 we qualified for $3.1 million in tax credits for which we expect to realize $2.8 million in cash proceeds during the fourth quarter of fiscal 2018.  In April 2017 we received $3.3 million in proceeds, net of costs, from the sale of the tax credits we earned in fiscal 2016. For fiscal 2018 our average eligible jobs are expected to be lower than in fiscal 2017 and we project that we will receive approximately $3.0 million of transferrable tax credits with a pretax realizable value of approximately $2.6 million, subject to our compliance with the requirements under our Grow NJ award. Cost reductions from lower headcount are expected to more than offset any decline in the amount realized from our incentive package.

Based on our current operating plan, our management believes that our current cash and working capital positions, expected operating cash flows and available borrowing capacity, will be sufficient to fund our cash requirements for working capital and capital expenditures for at least the next 12 months. We have based this belief on assumptions that we believe are reasonable but may not be realized due to a variety of factors including lower than anticipated net sales or gross margins, increased expenses, continued or declining levels of economic or retail industry conditions, or other events, including those factors discussed in Part I, Item 1A “Risk Factors” of our Annual Report on Form 10-K for the fiscal year ended February 3, 2018. As a result, we could use our available capital resources sooner than we currently expect. Furthermore, our operating plan may change, and we may need additional funds sooner than planned. If we are unable to obtain required funds from the aforementioned sources or to complete the financing transaction for our new senior secured facility contemplated by the commitment letter with Bank of America, we will likely need to seek other sources of financing which may not be on favorable terms. as well as defer, reduce or eliminate planned expenditures, which would likely impair our growth prospects and could otherwise negatively impact our business.

29

Contractual Obligations

There have been no material changes since February 3, 2018, outside of the ordinary course of business, to contractual obligations specified in the table of contractual obligations and commercial commitments in the section “Management’s Discussion and Analysis of Financial Condition and Results of Operations” included in our Annual Report on Form 10-K for the fiscal year ended February 3, 2018.

Off-Balance Sheet Financing Arrangements

We do not have any material off-balance sheet financing arrangements.

Critical Accounting Policies and Estimates

Our consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States. These generally accepted accounting principles require management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of our consolidated financial statements and the reported amounts of net sales and expenses during the reporting period. Our critical accounting policies are described in “Item 7. Management’s Discussion and Analysis of Financial Condition and Results of Operations” in our Annual Report on Form 10-K for the fiscal year ended February 3, 2018. In conjunction with the adoption of ASU No. 2014-09, Revenue from Contracts with Customers on February 3, 2018 we began including the asset for recovery component of our sales return reserve in Prepaid expenses and other current assets on our consolidated balance sheets.   Prior to the adoption of this ASU this asset had been recorded as a component of Inventory.  As of November 3, 2018, there were no other material changes in, or additions to, our critical accounting policies or in the assumptions or estimates we used to prepare the financial information appearing in this report.

Recent Accounting Pronouncements

Adopted

In May 2017 the Financial Accounting Standards Board (“FASB”) issued Accounting Standards Update (“ASU”) No. 2017-09, Compensation - Stock Compensation (Topic 718): Scope of Modification Accounting. ASU 2017-09 provides guidance about which changes to the terms or conditions of a share-based payment award require an entity to apply modification accounting in Topic 718. ASU No. 2017-09 is effective for financial statements issued for annual reporting periods beginning after December 15, 2017 and interim periods within those years. Earlier application is permitted. We adopted ASU No. 2017-09 effective February 4, 2018 and the adoption did not have a material impact on our consolidated financial position, results of operations or cash flows.

In October 2016 the FASB issued ASU No. 2016-16, Income Taxes (Topic 740): Intra-Entity Transfers of Assets Other Than Inventory. ASU No. 2016-16 amends the accounting for income taxes and requires the recognition of the income tax consequences of an intercompany asset transfer, other than transfers of inventory, when the transfer occurs. For intercompany transfers of inventory, the income tax effects will continue to be deferred until the inventory has been sold to a third party. ASU No. 2016-16 is effective for financial statements issued for annual reporting periods beginning after December 15, 2017 and interim periods within those years, using a modified retrospective application method through a cumulative-effect adjustment directly to retained earnings as of the beginning of the period of adoption. Earlier application is permitted. We adopted ASU No. 2016-16 effective February 4, 2018 and the adoption did not have a material impact on our consolidated financial position, results of operations or cash flows.

In August 2016 the FASB issued ASU No. 2016-15, Statement of Cash Flows (Topic 230): Classification of Certain Cash Receipts and Cash Payments. ASU No. 2016-15 clarifies and provides guidance on eight specific cash flow classification issues and is intended to reduce existing diversity in practice in how certain cash receipts and cash payments are presented and classified in the statement of cash flows. ASU No. 2016-15 is effective for annual reporting periods beginning after December 15, 2017 and interim periods within those years. Earlier application is permitted, provided that all of the amendments are adopted in the same period. We adopted ASU No. 2016-15 effective February 4, 2018 and the adoption did not have any impact on our consolidated financial position, results of operations or cash flows.

In May 2014 the FASB issued ASU No. 2014-09, Revenue from Contracts with Customers (Topic 606). ASU No. 2014-09 requires an entity to recognize revenue for the amount of consideration to which it expects to be entitled for the transfer of promised goods or services to customers. Additionally, ASU No. 2014-09 requires improved disclosures to help users of financial statements better understand the nature, amount, timing, and uncertainty of revenue that is recognized. The standard replaced most existing revenue recognition guidance in GAAP when it became effective. ASU No. 2014-09 is effective for financial statements issued for annual reporting periods beginning after December 15, 2016 and interim periods within those years. In August 2015 the FASB issued ASU No. 2015-14, Revenue from Contracts with Customers (Topic 606): Deferral of the Effective Date which deferred the effective date of ASU No. 2014-09 by one year, making the guidance effective for fiscal years beginning after December 15, 2017.

30

Management adopted this guidance on February 3, 2018 using the modified retrospective approach.  This ASU required that sales return reserves be presented on a gross basis as a refund liability and an asset for recovery and that the asset be reported separate from inventory on our consolidated balance sheet.  Prior to the adoption of this ASU we had recorded our sales return reserve on a gross basis with the asset for recovery recorded as a component of inventory. The impact of adoption on our consolidated balance sheet as of November 3, 2018 is as follows:

						Excluding ASU
(in thousands)	As Reported		ASU 2014-09 Effect			2014-09 Effect
Inventories	$	79,054	$	(1,070	)	$	77,984
Prepaid expenses and other current assets		10,270		1,070			11,340

There was no impact from adoption on our consolidated statements of operations or consolidated statements of cash flow.  

Not Yet Adopted

In February 2016 the FASB issued ASU No. 2016-02, Leases (Topic 842). ASU No. 2016-02 affects any entity that enters into a lease (as that term is defined in the ASU) and its guidance supersedes Topic 840, Leases. As it substantively relates to us, ASU No. 2016-02 requires lessees to recognize a right-of-use asset and a lease liability, initially measured at the present value of the lease payments, in the statement of financial position. For finance leases, lessees are required to recognize interest on the lease liability separately from amortization of the right-of-use asset in the statement of comprehensive income and to classify repayments of the principal portion of the lease liability within financing activities and payments of interest on the lease liability and variable lease payments within operating activities in the statement of cash flows. For operating leases, lessees are required to recognize a single lease cost, calculated so that the cost of the lease is allocated over the lease term on a generally straight-line basis, and to classify all cash payments within operating activities in the statement of cash flows. In transition, lessees are required to recognize and measure leases at the beginning of the earliest period presented using a modified retrospective approach. ASU No. 2016-02 is effective for financial statements issued for annual reporting periods beginning after December 15, 2018 and interim periods within those years. Earlier application is permitted. The Company has implemented its leasing software solution and is in the process of validating output.  We are also currently evaluating the provisions of this standard including the finalization of the use of practical expedients and assessing our existing lease portfolio in order to determine the impact on our accounting systems, processes and internal controls over financial reporting. While the Company is still evaluating this standard, given the significant number of leases the Company is party to, the Company expects this standard will have a material impact on the Company's consolidated financial statements. The standard will have no impact on our debt-covenant compliance under our current agreements.

In August 2018, the FASB issued ASU 2018-15, Customer's Accounting for Implementation Costs Incurred in a Cloud Computing Arrangement that is a Service Contract. ASU 2018-15 requires implementation costs incurred by customers in cloud computing arrangements to be deferred over the non-cancellable term of the cloud computing arrangements plus any optional renewal periods (1) that are reasonably certain to be exercised by the customer or (2) for which exercise of the renewal option is controlled by the cloud service provider. The effective date of this pronouncement is for fiscal years beginning after December 15, 2019, and interim periods within those fiscal years, and early adoption is permitted. The standard can be adopted either using the prospective or retrospective transition approach. The Company is currently evaluating the impact of this pronouncement on the Company's consolidated financial statements and disclosures.

Item 3. Quantitative and Qualitative Disclosures About Market Risk

We are exposed to market risk from changes in interest rates. We have not entered into any market sensitive instruments for trading purposes. The analysis below presents the sensitivity of the market value of our financial instruments to selected changes in market interest rates. The range of changes presented reflects our view of changes that are reasonably possible over a one-year period.

As of November 3, 2018, we had cash and cash equivalents of $1.2 million. Our cash equivalents consist of investments in money market funds that bear interest at variable rates. A change in market interest rates earned on our investments impacts the interest income and cash flows but does not materially impact the fair market value of the financial instruments. Due to the low balance, average maturity and conservative nature of our investment portfolio, we believe a sudden change in interest rates would not have a material effect on the value of our investment portfolio. The impact on our future interest income resulting from changes in investment yields will depend largely on the gross amount of our investment portfolio at that time. However, based upon the conservative nature of our investment portfolio and current experience, we do not believe a decrease in investment yields would have a material negative effect on our interest income.

31

As of November 3, 2018, our indebtedness consisted of the $24.4 million outstanding under our Term Loan, the $3.7 million and $1.7 million principal balances of our equipment notes, and $21.7 million outstanding under the Credit Facility. All of our indebtedness is denominated in United States dollars. The fair value of our indebtedness is referred to as the “debt value.” The equipment notes bear interest at a weighted fixed rate of 6.3%. Although a change in market interest rates would not affect the interest incurred or cash flow related to this fixed rate portion of our indebtedness, the debt value would be affected.

The Term Loan carries a variable interest rate that is tied to market indices with a minimum annual rate of 9.0%. The sensitivity analysis as it relates to this portion of our debt portfolio assumes an instantaneous 100 basis point move in interest rates above and below the minimum threshold, with all other variables held constant. The debt value of the Term Loan is approximately $24.4 million. A 100-basis point increase in market interest rates above the minimum threshold would result in additional annual interest expense on the Term Loan of approximately $0.2 million. A 100-basis point decline in market interest rates below the minimum threshold would have no effect on our annual interest expense on the Term Loan.

Our Credit Facility has variable interest rates that are tied to market indices. As of November 3, 2018, we had $21.7 million of direct borrowings and $7.3 million of letters of credit outstanding under our Credit Facility. As of November 3, 2018, borrowings under the Credit Facility would have resulted in interest at a rate between 3.81% and 5.75% per annum. Interest on any future borrowings under the Credit Facility would, to the extent of outstanding borrowings, be affected by changes in market interest rates. A change in market interest rates on the variable rate portion of our indebtedness would impact the interest expense incurred and cash flows.

The sensitivity analysis as it relates to the fixed rate portion of our indebtedness assumes an instantaneous 100 basis point move in interest rates from their levels as of November 3, 2018, with all other variables held constant. A 100-basis point increase in market interest rates would result in a decrease in the value of the debt by approximately $23,000 as of November 3, 2018. A 100-basis point decline in market interest rates would cause the debt value to increase by approximately $23,000 as of November 3, 2018.

Item 4. Controls and Procedures

Disclosure Controls and Procedures

Our disclosure controls and procedures are designed to ensure that information required to be disclosed by us in the reports that are filed or submitted under the Exchange Act is recorded, processed, summarized and reported within the time periods specified in the SEC’s rules and forms. These disclosure controls and procedures include controls and procedures designed to ensure that information required to be disclosed under the Exchange Act is accumulated and communicated to our management on a timely basis to allow decisions regarding required disclosure. We evaluated the effectiveness of the design and operation of our disclosure controls and procedures as of November 3, 2018. Based on this evaluation, our Chief Executive Officer and Chief Accounting Officer have concluded that as of November 3, 2018 these controls and procedures were effective.

Internal Control over Financial Reporting

There have been no changes in internal control over financial reporting identified in connection with the foregoing evaluation that occurred during the fiscal quarter ended November 3, 2018 that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.

32

PART II—OTHER INFORMATION

Item 1. Legal Proceedings

From time to time, we are named as a defendant in legal actions arising from our normal business activities. Litigation is inherently unpredictable and although the amount of any liability that could arise with respect to currently pending actions cannot be accurately predicted, we do not believe that the resolution of any pending action will have a material adverse effect on our financial position, results of operations or liquidity.

Item 1A. Risk Factors

In addition to the other information set forth in this Form 10-Q, you should carefully consider the factors discussed in Part I, Item 1A “Risk Factors” of our Annual Report on Form 10-K for the fiscal year ended February 3, 2018. The risks described in our Annual report on Form 10-K are not the only risks that we face. Additional risks not presently known to us or that we do not currently consider significant may also have an adverse effect on us. If any of the risks actually occur, our business, results of operations, cash flows or financial condition could be adversely impacted.

Item 2. Unregistered Sales of Equity Securities and Use of Proceeds

The following table provides information about purchases by us during the three-month period August 5, 2018 to November 3, 2018 of our Common Stock that is registered by us pursuant to Section 12 of the Exchange Act:

Period	Total Number of Shares Purchased (1)		Average Price Paid per Share		Total Number of Shares Purchased as Part of a Publicly Announced Program (2)		Maximum Approximate Dollar Value of Shares that May Yet Be Purchased Under the Program (2)
August 5 to September 1, 2018		—	$	-		—		—
September 2 to October 6, 2018		334		4.31		—		—
October 7 to November 3, 2018		25,380		4.29		—		—
Total		25,714	$	4.29		—		—

(1) Represents shares of Common Stock reacquired by us from certain employees to satisfy income tax withholding obligations for such employees in connection with restricted stock awards that vested during the period.

Item 3. Defaults Upon Senior Securities

None

Item 4. Mine Safety Disclosures

None

Item 5. Other Information

None

33

Item 6. Exhibits

Exhibit No.		Description
3.1		Restated Certificate of Incorporation of the Company (Exhibit 3.1 to the Company’s Annual Report on Form 10-K for the fiscal year ended September 30, 2008, filed on December 15, 2008).
3.2		Bylaws of the Company, effective December 22, 2016 (Exhibit 3.2 to the Company’s Annual Report on Form 10-K for the fiscal year ended February 3, 2018, filed on April 19, 2018).
10.1		Executive Employment Agreement, dated November 1, 2018, between the Company and Marla A. Ryan (incorporated by reference to Exhibit 10.1 to the Company’s Current Report on Form 8-K dated November 1, 2018).
10.2		Time-Based Restricted Stock Unit Award Agreement, dated November 1, 2018, between the Company and Marla A. Ryan (incorporated by reference to Exhibit 10.2 to the Company’s Current Report on Form 8-K dated November 1, 2018).
10.3		Performance Based Restricted Stock Unit Award Agreement, dated November 1, 2018, between the Company and  Marla A. Ryan (incorporated by reference to Exhibit 10.3 to the Company’s Current Report on Form 8-K dated November 1, 2018).
10.4		Non-Qualified Stock Option Agreement, dated November 1, 2018, between the Company and Marla A. Ryan (incorporated by reference to Exhibit 10.4 to the Company’s Current Report on Form 8-K dated November 1, 2018)
10.5		Commitment Letter, dated September 26, 2018, between the Company and Bank of America, N.A. (incorporated by reference to Exhibit 10.1 to the Company’s Current Report on Form 8-K dated September 28, 2018).
31.1	*	Certification of the Chief Executive Officer Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002
31.2	*	Certification of the Senior Vice President & Chief Accounting Officer Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002
32.1	**	Certification of the Chief Executive Officer Pursuant to 18 U.S.C. Section 1350, as Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002
32.2	**	Certification of the Senior Vice President & Chief Accounting Officer Pursuant to 18 U.S.C. Section 1350, as Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002
101.INS	*	XBRL Instance Document
101.SCH	*	XBRL Taxonomy Extension Schema Document
101.CAL	*	XBRL Taxonomy Extension Calculation Linkbase Document
101.DEF	*	XBRL Taxonomy Extension Definition Linkbase Document
101.LAB	*	XBRL Taxonomy Extension Label Linkbase Document
101.PRE	*	XBRL Taxonomy Extension Presentation Linkbase Document

* filed herewith

** furnished herewith

34

Signatures

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

	Destination Maternity Corporation
Date: December 11, 2018	By:	/s/ MARLA A. RYAN
		Marla A. Ryan
		Chief Executive Officer
Date: December 11, 2018	By:	/s/ RODNEY SCHRIVER
		Rodney Schriver
		Senior Vice President & Chief Accounting Officer

35

EX-31.1

Exhibit 31.1

SARBANES-OXLEY

SECTION 302 CERTIFICATION

I, Marla A. Ryan, certify that:

1. I have reviewed this Quarterly Report on Form 10-Q of Destination Maternity Corporation;

2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4. The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

(a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

(b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

(c) Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

(d) Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

5. The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors:

(a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

(b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

December 11, 2018	/s/ MARLA A. RYAN
Date	Marla A. Ryan
	Chief Executive Officer

EX-31.2

Exhibit 31.2

SARBANES-OXLEY

SECTION 302 CERTIFICATION

I, Rodney Schriver, certify that:

1. I have reviewed this Quarterly Report on Form 10-Q of Destination Maternity Corporation;

2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4. The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

(a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

(b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

(c) Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

(d) Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

5. The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors:

(a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

(b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

December 11, 2018	/s/ RODNEY SCHRIVER
Date	Rodney Schriver
	Senior Vice President & Chief Accounting Officer

EX-32.1

Exhibit 32.1

CERTIFICATION PURSUANT TO

18 U.S.C. SECTION 1350,

AS ADOPTED PURSUANT TO

SECTION 906 OF THE SARBANES–OXLEY ACT OF 2002

In connection with the Quarterly Report of Destination Maternity Corporation (the “Company”) on Form 10-Q for the period ended November 3, 2018 as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I, Marla A. Ryan, Chief Executive Officer of the Company, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that, to her knowledge:

(1) The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

(2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

/s/ MARLA A. RYAN

Marla A. Ryan

Chief Executive Officer

December 11, 2018

EX-32.2

Exhibit 32.2

CERTIFICATION PURSUANT TO

18 U.S.C. SECTION 1350,

AS ADOPTED PURSUANT TO

SECTION 906 OF THE SARBANES–OXLEY ACT OF 2002

In connection with the Quarterly Report of Destination Maternity Corporation (the “Company”) on Form 10-Q for the period ended November 3, 2018 as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I, Rodney Schriver, Senior Vice President & Chief Accounting Officer of the Company, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that, to his knowledge:

(1) The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

(2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

/s/ RODNEY SCHRIVER

Rodney Schriver

Senior Vice President & Chief Accounting Officer

December 11, 2018

XML

Document and Entity Information - shares	9 Months Ended
	Nov. 03, 2018	Nov. 30, 2018
Document And Entity Information [Abstract]
Document Type	10-Q
Amendment Flag	false
Document Period End Date	Nov. 03, 2018
Document Fiscal Year Focus	2018
Document Fiscal Period Focus	Q3
Trading Symbol	DEST
Entity Registrant Name	Destination Maternity Corp
Entity Central Index Key	0000896985
Current Fiscal Year End Date	--02-02
Entity Filer Category	Non-accelerated Filer
Entity Small Business	true
Entity Emerging Growth Company	false
Entity Common Stock, Shares Outstanding		14,447,524

XML

CONSOLIDATED BALANCE SHEETS (unaudited) - USD ($) $ in Thousands	Nov. 03, 2018	Feb. 03, 2018
Current assets:
Cash and cash equivalents	$ 1,247	$ 1,635
Trade receivables, net	7,261	6,692
Inventories	79,054	71,256
Prepaid expenses and other current assets	10,270	11,522
Total current assets	97,832	91,105
Property and equipment, net of accumulated depreciation and amortization of $106,276 and $98,024	55,158	66,146
Other assets:
Deferred line of credit financing costs, net of accumulated amortization of $898 and $829	383	450
Other intangible assets, net of accumulated amortization of $1,027 and $907	863	953
Deferred income taxes	4,805	2,829
Other non-current assets	1,064	1,099
Total other assets	7,115	5,331
Total assets	160,105	162,582
Current liabilities:
Line of credit borrowings	21,700	8,000
Current portion of long-term debt	4,729	4,780
Accounts payable	25,767	30,949
Accrued expenses and other current liabilities	30,988	31,661
Total current liabilities	83,184	75,390
Long-term debt	22,704	23,809
Deferred rent and other non-current liabilities	20,856	22,715
Total liabilities	126,744	121,914
Commitments and contingencies (Note 15)
Stockholders’ equity:
Preferred stock, 1,656,381 shares authorized, none outstanding
Common stock, $.01 par value; 20,000,000 shares authorized, 14,447,524 and 14,684,117 shares issued and outstanding	145	147
Additional paid-in capital	107,482	106,865
Accumulated deficit	(74,192)	(66,274)
Accumulated other comprehensive loss	(74)	(70)
Total stockholders’ equity	33,361	40,668
Total liabilities and stockholders’ equity	$ 160,105	$ 162,582

XML

CONSOLIDATED BALANCE SHEETS (unaudited) (Parenthetical) - USD ($) $ in Thousands	Nov. 03, 2018	Feb. 03, 2018
Statement Of Financial Position [Abstract]
Property and equipment, accumulated depreciation and amortization	$ 106,276	$ 98,024
Deferred line of credit financing costs, accumulated amortization	898	829
Other intangible assets, accumulated amortization	$ 1,027	$ 907
Preferred stock, shares authorized	1,656,381	1,656,381
Preferred stock, shares outstanding	0	0
Common stock, par value	$ 0.01	$ 0.01
Common stock, shares authorized	20,000,000	20,000,000
Common stock, shares issued	14,447,524	14,684,117
Common stock, shares outstanding	14,447,524	14,684,117

XML

CONSOLIDATED STATEMENTS OF OPERATIONS (unaudited) - USD ($) shares in Thousands, $ in Thousands	3 Months Ended		9 Months Ended
	Nov. 03, 2018	Oct. 28, 2017	Nov. 03, 2018	Oct. 28, 2017
Income Statement [Abstract]
Net sales	$ 92,837	$ 96,354	$ 292,459	$ 301,060
Type of Revenue [Extensible List]	us-gaap:ProductMember	us-gaap:ProductMember	us-gaap:ProductMember	us-gaap:ProductMember
Cost of goods sold	$ 44,181	$ 45,453	$ 138,535	$ 140,167
Type of Cost, Good or Service [Extensible List]	us-gaap:ProductMember	us-gaap:ProductMember	us-gaap:ProductMember	us-gaap:ProductMember
Gross profit	$ 48,656	$ 50,901	$ 153,924	$ 160,893
Selling, general and administrative expenses	48,629	53,234	150,581	161,689
Store closing, asset impairment and asset disposal expenses	1,028	1,011	2,669	3,649
Other charges, net	1,825	3,100	4,898	3,746
Operating loss	(2,826)	(6,444)	(4,224)	(8,191)
Interest expense, net	1,232	1,006	3,533	2,989
Loss before income taxes	(4,058)	(7,450)	(7,757)	(11,180)
Income tax provision	56	73	168	259
Net loss	$ (4,114)	$ (7,523)	$ (7,925)	$ (11,439)
Net loss per share— Basic	$ (0.30)	$ (0.55)	$ (0.57)	$ (0.83)
Average shares outstanding— Basic	13,895	13,800	13,867	13,777
Net loss per share— Diluted	$ (0.30)	$ (0.55)	$ (0.57)	$ (0.83)
Average shares outstanding— Diluted	13,895	13,800	13,867	13,777

XML

CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (LOSS) (unaudited) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Nov. 03, 2018	Oct. 28, 2017	Nov. 03, 2018	Oct. 28, 2017
Statement Of Income And Comprehensive Income [Abstract]
Net loss	$ (4,114)	$ (7,523)	$ (7,925)	$ (11,439)
Foreign currency translation adjustments	(2)		(4)	2
Comprehensive loss	$ (4,116)	$ (7,523)	$ (7,929)	$ (11,437)

XML

CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY (unaudited) - USD ($) shares in Thousands, $ in Thousands	Total	Common Stock	Additional Paid-in Capital	Accumulated Deficit	Accumulated Other Comprehensive Loss
Beginning Balance at Jan. 28, 2017	$ 61,150	$ 140	$ 105,775	$ (44,693)	$ (72)
Beginning Balance, shares at Jan. 28, 2017		14,010
Net loss	(11,439)			(11,439)
Foreign currency translation adjustments	2				2
Dividends forfeited	15			15
Stock-based compensation	858	$ 6	852
Stock-based compensation, shares		616
Repurchase and retirement of common stock	(45)		(45)
Repurchase and retirement of common stock, shares		(15)
Ending Balance at Oct. 28, 2017	50,541	$ 146	106,582	(56,117)	(70)
Ending Balance, shares at Oct. 28, 2017		14,611
Beginning Balance at Feb. 03, 2018	40,668	$ 147	106,865	(66,274)	(70)
Beginning Balance, shares at Feb. 03, 2018		14,684
Net loss	(7,925)			(7,925)
Foreign currency translation adjustments	(4)				(4)
Dividends forfeited	7			7
Stock-based compensation	750	$ 5	745
Stock-based compensation, shares		477
Exercise of stock options, net	1	$ 0	1
Exercise of stock options, shares		0
Repurchase and retirement of common stock	(136)	$ (7)	(129)
Repurchase and retirement of common stock, shares		(683)
Ending Balance at Nov. 03, 2018	$ 33,361	$ 145	$ 107,482	$ (74,192)	$ (74)
Ending Balance, shares at Nov. 03, 2018		14,478

XML

CONSOLIDATED STATEMENTS OF CASH FLOWS (unaudited) - USD ($) $ in Thousands	9 Months Ended
	Nov. 03, 2018	Oct. 28, 2017
Operating Activities
Net loss	$ (7,925)	$ (11,439)
Adjustments to reconcile net loss to net cash provided by operating activities:
Depreciation and amortization	11,789	13,259
Stock-based compensation expense	750	858
Loss on impairment of long-lived assets	2,236	3,267
Loss on disposal of assets	238	283
Grow NJ award benefit	(1,977)	1,096
Amortization of deferred financing costs	506	375
Decrease (increase) in:
Trade receivables	(569)	(1,218)
Inventories	(7,798)	(4,896)
Prepaid expenses and other current assets	1,251	3,110
Other non-current assets	35	(59)
(Decrease) increase in:
Accounts payable, accrued expenses and other current liabilities	(3,861)	2,474
Deferred rent and other non-current liabilities	(2,087)	23
Net cash provided by (used in) operating activities	(7,412)	7,133
Investing Activities
Capital expenditures	(3,456)	(5,484)
Additions to intangible assets		(18)
Net cash used in investing activities	(3,456)	(5,502)
Financing Activities
Decrease in cash overdraft	(1,486)	(461)
Increase in line of credit borrowings	13,700	3,600
Proceeds from long-term debt	2,500	3,401
Repayment of long-term debt	(3,935)	(8,493)
Deferred financing costs paid	(160)	(277)
Withholding taxes on stock-based compensation paid in connection with repurchase of common stock	(136)	(45)
Proceeds from exercise of stock options	1
Net cash provided by (used in) financing activities	10,484	(2,275)
Effect of exchange rate changes on cash and cash equivalents	(4)	2
Net Decrease in Cash and Cash Equivalents	(388)	(642)
Cash and Cash Equivalents, Beginning of Period	1,635	2,859
Cash and Cash Equivalents, End of Period	1,247	2,217
Supplemental Disclosures of Cash Flow Information:
Cash paid for interest	2,997	2,640
Cash (received) paid for income taxes	$ 118	$ (4,240)

XML

Basis of Financial Statement Presentation

9 Months Ended

Nov. 03, 2018

Organization Consolidation And Presentation Of Financial Statements [Abstract]

Basis of Financial Statement Presentation

1. BASIS OF FINANCIAL STATEMENT PRESENTATION

The accompanying unaudited consolidated financial statements for the three and nine months ended November 3, 2018 and October 28, 2017 have been prepared in accordance with the requirements for Form 10-Q and Article 10 of Regulation S-X, and accordingly, certain information and footnote disclosures have been condensed or omitted. See the Company’s Annual Report on Form 10-K as of and for the year ended February 3, 2018 for Destination Maternity Corporation and subsidiaries (the “Company” or “Destination Maternity”) as filed with the Securities and Exchange Commission (“SEC”) for additional disclosures including a summary of the Company’s accounting policies.

In the opinion of management, the consolidated financial statements contain all adjustments, consisting of normal recurring adjustments, necessary to present fairly the consolidated financial position, results of operations and cash flows of the Company for the periods presented. Since the Company’s operations are seasonal, the interim operating results of the Company may not be indicative of operating results for the full year. Certain prior year amounts have been reclassified to conform to the current year presentation.

The Company operates on a 52/53-week fiscal year ending on the Saturday nearest January 31 of each year. References to the Company’s fiscal 2018 refer to the 52-week fiscal year, or periods within such fiscal year, which began February 4, 2018 and will end February 2, 2019. References to the Company’s fiscal 2017 refer to the 53-week fiscal year, or periods within such fiscal year, which began January 29, 2017 and ended February 3, 2018.

XML

Earnings Per Share ("EPS") and Dividends

9 Months Ended

Nov. 03, 2018

Earnings Per Share [Abstract]

Earnings Per Share ("EPS") and Dividends

2. EARNINGS PER SHARE (“EPS”) AND DIVIDENDS

Basic net loss per share (“Basic EPS”) is computed by dividing net loss by the weighted average number of common shares outstanding, excluding restricted stock awards for which the restrictions have not lapsed. Diluted net loss per share (“Diluted EPS”) is computed by dividing net loss by the weighted average number of common shares outstanding, after giving effect to the potential dilution, if applicable, from the assumed lapse of restrictions on restricted stock and restricted stock unit (“RSU”) awards, and from shares of common stock resulting from the assumed exercise of outstanding stock options. Common shares issuable in connection with the award of performance-based restricted stock units (“PRSUs”) are excluded from the calculation of EPS until the PRSUs’ performance conditions are achieved and the shares in respect of the PRSUs become issuable (see Note 13).

The following tables summarize the Basic EPS and Diluted EPS calculations (in thousands, except per share amounts):

	Three Months Ended
	November 3, 2018								October 28, 2017
	Net Loss			Shares		EPS			Net Loss			Shares		EPS
Basic and Diluted EPS	$	(4,114	)		13,895	$	(0.30	)	$	(7,523	)		13,800	$	(0.55	)

	Nine Months Ended
	November 3, 2018								October 28, 2017
	Net Loss			Shares		EPS			Net Loss			Shares		EPS
Basic and Diluted EPS	$	(7,925	)		13,867	$	(0.57	)	$	(11,439	)		13,777	$	(0.83	)

In addition to PRSUs, for the three and nine months ended November 3, 2018 stock options and unvested restricted stock totaling approximately 436,000 and 804,000 shares, respectively, were excluded from the calculation of Diluted EPS as their effect would have been antidilutive. Stock options and unvested restricted stock totaling approximately 1,130,000 and 1,604,000 shares of the Company’s common stock were outstanding as of November 3, 2018 and October 28, 2017, respectively, but were not included in the computation of Diluted EPS for the three and nine months ended November 3, 2018 and October 28, 2017 due to the Company’s net loss. If the Company had reported a profit for the three and nine months ended November 3, 2018 and for the three and nine months ended October 28, 2017 the weighted average number of dilutive shares outstanding for computation of Diluted EPS would have been approximately 14,186,000, 14,159,000, 13,811,000 and 13,797,000 shares, respectively.

During the nine months ended November 3, 2018 and October 28, 2017, $7,000 and $15,000, respectively, of previously declared and undistributed dividends, for which payment was subject to completion of service requirements under restricted stock awards, were forfeited back to the Company in connection with the cancellation of the restricted stock awards.

XML

Trade Receivables

9 Months Ended

Nov. 03, 2018

Receivables [Abstract]

Trade Receivables

3. TRADE RECEIVABLES

Trade receivables are recorded based on revenue recognized for sales of the Company’s merchandise and for other revenue earned by the Company through its marketing partnership programs and international franchise agreements, and are non-interest bearing. The Company evaluates the collectability of trade receivables based on a combination of factors, including aging of trade receivables, write-off experience, analysis of historical trends and expectations of future performance. An allowance for doubtful accounts is recorded for the amount of trade receivables that are considered unlikely to be collected. When the Company’s collection efforts are unsuccessful, uncollectible trade receivables are charged against the allowance for doubtful accounts. As of November 3, 2018, and February 3, 2018 the Company’s trade receivables were net of allowance for doubtful accounts of $166,000 and $166,000, respectively.

XML

Inventories

9 Months Ended

Nov. 03, 2018

Inventory Disclosure [Abstract]

Inventories

4. INVENTORIES

Inventories were comprised of the following (in thousands):

	November 3, 2018		February 3, 2018
Finished goods	$	78,711	$	70,687
Work-in-progress		142		182
Raw materials		201		387
	$	79,054	$	71,256

XML

Accrued Expenses and Other Current Liabilities

9 Months Ended

Nov. 03, 2018

Payables And Accruals [Abstract]

Accrued Expenses and Other Current Liabilities

5. ACCRUED EXPENSES AND OTHER CURRENT LIABILITIES

Accrued expenses and other current liabilities were comprised of the following (in thousands):

	November 3, 2018		February 3, 2018
Employee compensation and benefits	$	6,256	$	7,133
Accrued expenses		4,866		3,244
Insurance, primarily self-insurance reserves		3,858		5,048
Deferred rent		2,983		3,211
Sales and use taxes		2,827		2,638
Gift certificates and store credits		2,832		3,385
Product return reserve		2,298		2,799
Deferred revenue		1,668		1,001
Audit and legal		1,399		714
Accrued property and equipment additions		185		218
Other		1,816		2,270
	$	30,988	$	31,661

XML

Line of Credit

9 Months Ended

Nov. 03, 2018

Debt Disclosure [Abstract]

Line of Credit

6. LINE OF CREDIT

After completion of a debt refinancing on February 1, 2018 the Company has in place a $50,000,000 senior secured revolving credit facility (the “Credit Facility”), which was amended and restated in connection with the issuance of the Company’s $25,000,000 Term Loan (see Note 7). The Company’s previous $70,000,000 Credit Facility had been in place since March 25, 2016. In connection with the Term Loan financing the maturity date of the Credit Facility was extended to January 31, 2023 and certain availability reserves were reduced or eliminated. Proceeds from advances under the Credit Facility, subject to certain restrictions, may be used to provide financing for working capital, letters of credit, capital expenditures, and other general corporate purposes.

The Credit Facility contains various affirmative and negative covenants and representations and warranties including the requirement that the Company maintain Excess Availability (as defined in the related Credit Agreement) of more than the greater of 10% of the Combined Loan Caps (as defined in the related Credit Agreement) and $7,000,000. In the event that the outstanding balance of the Term Loan exceeds the Term Loan Borrowing Base (as defined in the related Term Loan Agreement) then a reserve will be imposed against availability under the Credit Facility. The Credit Facility is secured by a security interest in the Company’s trade receivables, inventory, letter of credit rights, cash, intangibles and certain other assets. The interest rate on outstanding borrowings is equal to, at the Company’s election, either 1) the lender’s base rate plus 0.50% or 2) a LIBOR rate plus 1.0%. The Company also pays an unused line fee under the Credit Facility of 0.25% per annum.

Any amounts outstanding under the Credit Facility may be accelerated and become due and payable immediately and all loan and letter of credit commitments thereunder may be terminated upon an event of default and expiration of any applicable cure period. Events of default include: 1) nonpayment of obligations due under the subject loan agreement and related loan documents, 2) cross-defaults to other indebtedness and documents, 3) failure to perform any covenant or agreement contained in the subject loan agreement, 4) material misrepresentations, 5) failure to pay, or certain other defaults under, other material indebtedness of the Company, 6) certain bankruptcy or insolvency events, 7) a change of control, 8) indictments of the Company or senior management in a material forfeiture action, 9) default under certain material contracts to the extent such termination or default has or could reasonably be expected to have a material adverse effect, and 10) customary ERISA defaults, among others.

In connection with the original execution and subsequent amendments of the Credit Facility, the Company incurred deferred financing costs of $1,280,000.  These deferred financing costs are being amortized over the term of the Credit Facility agreement and are included in “interest expense, net” in the consolidated statements of operations.

As of November 3, 2018, the Company had $21,700,000 in outstanding borrowings under the Credit Facility, $7,327,000 in letters of credit and $13,505,000 of availability based on the Company’s Borrowing Base formula and availability reserve requirements. As of October 28, 2017, the Company had $8,200,000 in outstanding borrowings under the previous Credit Facility, $7,327,000 in letters of credit and $12,531,000 of availability. For the three months ended November 3, 2018 and October 28, 2017 borrowings had a weighted interest rate of 4.22% and 3.87% per annum, respectively. For the nine months ended November 3, 2018 and October 28, 2017 borrowings had a weighted interest rate of 4.11% and 3.51% per annum, respectively.  During the nine months ended November 3, 2018 and October 28, 2017 the Company’s average levels of direct borrowings were $17,258,000 and $8,707,000, respectively, and the Company’s maximum borrowings were $27,400,000 and $15,700,000, respectively.

On September 26, 2018, the Company entered into a commitment letter with Bank of America N.A. (“Bank of America”),, pursuant to which, and subject to the terms and conditions set forth therein, Bank of America committed to provide to the Company certain five-year asset-based senior secured facilities consisting of an ABL with an aggregate commitment of $52 million and a FILO Term Loan with an aggregate principal amount of $24 million. The interest rates are expected to be, at the Company’s option, adjusted LIBOR or base rate plus an applicable margin based on excess availability. Such applicable margins for the base rate loans expect to range between 0.50% and 1.00% per annum in the case of the ABL and between 2.25% and 2.75% per annum in the case of the FILO Term Loan. Such applicable margins for the LIBOR loans expect to range between 1.5% to 2.0% in the case of the ABL and between 3.25% to 3.75% in the case of the FILO Term Loan. The funding of the senior secured facilities under the commitment letter is contingent upon the satisfaction of customary conditions, including, but not limited to, the parties’ entering into definitive documentation, absence of material adverse events or conditions with respect to the Company and the receipt of payoff letters in respect of the Company’s existing credit agreements governing its outstanding indebtedness. It is anticipated that the Company will use the net proceeds of the senior secured facilities to repay outstanding indebtedness under its Term Loan previously discussed in this Note 7 and under its Credit Facility previously discussed in Note 6, pay a portion of the transaction fees and expenses in connection with entering into the senior secured facilities and to the extent any net proceeds remain, for ongoing working capital and other general corporate purposes of the Company.

XML

Long-Term Debt

9 Months Ended

Nov. 03, 2018

Debt Disclosure [Abstract]

Long-Term Debt

7. LONG-TERM DEBT

On February 1, 2018 (the “Closing Date”) the Company entered into a Term Loan Credit Agreement (the “Term Loan Agreement”) which provides for a term loan of up to $25,000,000 and matures on January 31, 2023 (the “Term Loan”).  On the Closing Date the Company borrowed $22,500,000 net of fees against the Term Loan and used the proceeds, in addition to $3,600,000 borrowed under its Credit Facility (see Note 6) to pay off the $22,999,000 balance of the Company’s then existing term loan (the “Prior Term Loan”) and $3,226,000 of fees and interest associated with the refinancing transaction. The Term Loan provided for an additional loan of $2,500,000 which could be borrowed at the Company’s discretion within a period of 45 days after delivery to the lender of the Company’s first quarter fiscal 2018 financial statements and satisfaction of certain other requirements. The Company met these requirements and borrowed the additional $2,500,000 on July 16, 2018. There is a minimum excess availability requirement of the greater of 10% of the Combined Loan Cap, as defined in the Term Loan Agreement, or $7,000,000.    

The interest rate on the Term Loan is equal to a LIBOR rate plus 9.0%. The Company is required to make minimum repayments of the principal amount of the Term Loan in quarterly installments of $312,500 which commenced on July 31, 2018, with the remaining outstanding balance payable on the maturity date. Additionally, the Term Loan can be prepaid at the Company's option subject to certain restrictions and subject to a prepayment premium as follows: 1) if the prepayment occurs on or prior to the second anniversary of the Closing Date, the greater of  a) interest on the prepayment that would otherwise have been paid with the 24 month period following the Closing Date minus actual interest payments made through the prepayment date and b) 2% of the prepayment and 2) 2% of the prepayment amount if paid between the second and third anniversary of the Closing Date.

The Term Loan is secured by a security interest in substantially all of the assets of the Company, including accounts receivable, inventory, equipment, letter of credit rights, cash, intellectual property and other intangibles, and certain other assets. The security interest granted to the Term Lenders is, in certain respects, subordinate to the security interest granted to the Credit Facility Lender. The Term Loan Agreement prohibits the payment of dividends or share repurchases by the Company for three years and imposes certain restrictions on the Company's ability to, among other things, incur additional indebtedness and enter into other various types of transactions.

On September 26, 2018, the Company entered into a commitment letter with Bank of America, pursuant to which, and subject to the terms and conditions set forth therein, Bank of America committed to provide to the Company certain five-year asset-based senior secured facilities consisting of an ABL with an aggregate commitment of $52 million and a FILO Term Loan with an aggregate principal amount of $24 million. The interest rates are expected to be, at the Company’s option, adjusted LIBOR or base rate plus an applicable margin based on excess availability. Such applicable margins for the base rate loans expect to range between 0.50% and 1.00% per annum in the case of the ABL and between 2.25% and 2.75% per annum in the case of the FILO Term Loan. Such applicable margins for the LIBOR loans expect to range between 1.5% to 2.0% in the case of the ABL and between 3.25% to 3.75% in the case of the FILO Term Loan. The funding of the senior secured facilities under the commitment letter is contingent upon the satisfaction of customary conditions, including, but not limited to, the parties’ entering into definitive documentation, absence of material adverse events or conditions with respect to the Company and the receipt of payoff letters in respect of the Company’s existing credit agreements governing its outstanding indebtedness. It is anticipated that the Company will use the net proceeds of the senior secured facilities to repay outstanding indebtedness under its Term Loan previously discussed in this Note 7 and under its Credit Facility previously discussed in Note 6, pay a portion of the transaction fees and expenses in connection with entering into the senior secured facilities and to the extent any net proceeds remain, for ongoing working capital and other general corporate purposes of the Company.

On March 25, 2016 the Company entered into a Term Loan Agreement Credit Agreement (the “Prior Term Loan Agreement”) for the Company’s $32,000,000 Prior Term Loan that had a maturity date of March 25, 2021. The proceeds of the Prior Term Loan were used to repay a portion of the indebtedness that was outstanding under the Company’s credit facility at that time.  The interest rate on the Prior Term Loan was equal to a LIBOR rate (with a 1.0% LIBOR floor) plus 7.5%. The Company was required to make minimum repayments of the principal amount in quarterly installments of $800,000 with the remaining outstanding balance payable on the maturity date.  As amended on December 19, 2016 and April 7, 2017, the Prior Term Loan Agreement contained various minimum excess availability requirements including $5,000,000 against availability under the Company Credit Facility that was reduced dollar for dollar for prepayments of the Prior Term Loan, and an amount equal to the greater of 10% of the Combined Loan Cap (as defined in the Credit Facility Agreement) or $10,000,000.

In connection with the execution of the Term Loan Agreement, the Prior Term Loan Agreement and subsequent amendments, the Company incurred deferred financing costs of $4,557,000. Of this amount, the unamortized balance of $1,542,000 in deferred financing costs incurred in connection with the Prior Term Loan were written off upon entering into the Term Loan and charged to loss on extinguishment of debt in the Company consolidated statements of operations. There were $2,460,000 of deferred financing costs incurred in connection with the Term Loan. These deferred financing costs are reflected as a direct deduction from the Term Loan liability in the consolidated balance sheets and are being amortized over the term of the Term Loan Agreement. The amortization is included in “interest expense, net” in the consolidated statements of operations.

As of November 3, 2018, and October 28, 2017 there was $24,375,000 and $24,599,000, respectively, of principal outstanding under the Term Loan and Prior Term Loan.

As of November 3, 2018, and October 28, 2017 there was $3,730,000 and $7,064,000, respectively, outstanding under a five-year equipment financing arrangement with the Company’s Credit Facility bank. The equipment note bears annual interest at 3.38%, with payments of $272,000 (including interest) due monthly through December 2019. The equipment note is collateralized by substantially all of the material handling equipment at the Company’s distribution facility in Florence, New Jersey. Any amounts outstanding under the equipment note may be accelerated and become due and payable immediately upon an event of default and expiration of any applicable cure period. The specified events of default are substantially the same as those in the Credit Facility agreement (see Note 6).

On June 6, 2017 the Company received $3,401,000 in proceeds from a three-year financing arrangement in the form of a sale and leaseback for certain furniture, fixtures and software. Monthly payments under the leaseback arrangement are $123,000 for the first 24 months and $48,000 for months 25 to 36. At the end of the leaseback term, the Company has the option to extend the lease for an additional year or to repurchase the financed property for a price to be agreed. All of the proceeds from the transaction were used to prepay a portion of the Company’s Term Loan.  As of November 3, 2018, and October 28, 2017, there was $1,680,000 and $2,947,000 of principal outstanding under this financing arrangement.

XML

Fair Value Measurements

9 Months Ended

Nov. 03, 2018

Fair Value Disclosures [Abstract]

Fair Value Measurements

8. FAIR VALUE MEASUREMENTS

The accounting standard for fair value measurements defines fair value as the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. The standard establishes a framework for measuring fair value focused on exit price and creates a fair value hierarchy in order to increase the consistency and comparability of fair value measurements as follows:

• Level 1 – Quoted market prices in active markets for identical assets or liabilities

• Level 2 – Observable market-based inputs or inputs that are corroborated by observable market data

• Level 3 – Unobservable inputs that are not corroborated by market data

At both November 3, 2018 and February 3, 2018, the Company had cash equivalents of $4,000. The Company’s cash equivalents consist of investments in money market funds for which the carrying value approximates fair value (based on Level 1 inputs) due to the short-term nature of those instruments. The carrying values of trade receivables and accounts payable approximate fair value due to the short-term nature of those instruments.

The Company’s Credit Facility has variable interest rates that are tied to market indices. As of November 3, 2018, and February 3, 2018, the Company had $21,700,000 and $8,000,000, respectively, of direct borrowings outstanding under the Credit Facility. The carrying value of the Company’s Credit Facility borrowings approximates fair value as the variable interest rates approximate current market rates, which the Company considers to be Level 2 inputs.

The Company’s Term Loan, which represents a significant majority of the Company’s long-term debt, bears interest at variable rates, which adjust based on market conditions with a minimum annual rate of 9.00%. The carrying value of the Company’s Term Loan approximates fair value as the variable interest rates approximate current market rates for similar instruments available to companies with comparable credit quality, which the Company considers to be Level 2 inputs. The fair value of the Company’s fixed-rate equipment notes was determined using a discounted cash flow analysis based on interest rates currently available to the Company, which the Company considers to be Level 2 inputs. The difference between the carrying value and fair value of long-term debt held by the Company with a fixed rate of interest is not material.

XML

Net Sales

9 Months Ended

Nov. 03, 2018

Revenues [Abstract]

Net Sales

9. NET SALES

The following disaggregates the Company’s net sales by major source (in thousands):

	Three Months Ended				Nine Months Ended
	November 3, 2018		October 28, 2017		November 3, 2018		October 28, 2017
Retail stores	$	55,979	$	59,325	$	177,608	$	191,664
Leased departments		9,743		10,292		29,624		32,752
Total retail locations		65,722		69,617		207,232		224,416
Ecommerce		21,045		20,539		69,530		57,615
Marketing partnerships		4,110		4,475		12,236		13,004
Wholesale and franchise		1,960		1,723		3,461		6,025
Total net sales	$	92,837	$	96,354	$	292,459	$	301,060

The Company’s performance obligations consist primarily of transferring control of merchandise to customers.  Retail and ecommerce sales are recognized upon transfer of control, which occurs when merchandise is taken at point-of-sale for a retail transaction or upon receipt of shipment for an ecommerce transaction.  Sales are reported net of returns and sales taxes.  Shipping and handling fees billed to customers are recognized in net sales when control of the underling merchandise is transferred to the customer.

The Company earns revenue through a variety of marketing partnership programs utilizing the Company’s opt-in customer database and various in-store marketing initiatives focused on baby and parent-related products and services.  Revenue from these activities is recognized when the goods or services are provided.

Sales of product to the Company’s wholesale customers and international franchisees are recognized upon transfer of control which is primarily when product is shipped.  Franchise fees are recorded by the Company when all material services have been performed or in the case of royalties earned on sales of product, in the period when the franchisee sells product to their retail customer.

XML

Other Charges, Net

9 Months Ended

Nov. 03, 2018

Other Charges Net Related To Proxy Solicitation And Proposed Merger And Management And Organizational Changes [Abstract]

Other Charges, Net

10. OTHER CHARGES, NET

In the first quarter of fiscal 2018 the Company received notification from a stockholder group (the “Stockholder Group”), of the nomination of a slate of alternative nominees for election to the Company’s Board of Directors at the Annual Meeting of Stockholders that was held on May 23, 2018 (the “Proxy Solicitation”).  At the Company’s 2018 Annual Meeting of Stockholders held on May 23, 2018, the Company’s stockholders replaced the incumbent board in its entirety and elected Holly N. Alden, Christopher B. Morgan, Marla A Ryan and Anne-Charlotte Windal as the Company’s new Board of Directors. During the nine months ended November 3, 2018 the Company incurred $2,224,000 of charges related to the Proxy Solicitation, including $83,000 during the three months ended November 3, 2018.

During the fourth quarter of fiscal 2015 the Company entered into an Agreement and Plan of Merger (the “Merger Agreement”) with the Company’s largest shareholder, Orchestra, a France-based retailer of children’s wear, to complete a proposed business combination (“the Proposed Merger”).  During the second quarter of fiscal 2017 the parties determined that is was in the best interest of their respective stockholders to terminate the Merger and on July 27, 2017, the Company, Orchestra, and certain other affiliates of Orchestra entered into a Termination Agreement (the “Termination Agreement”).   In connection with the Termination Agreement, Orchestra and the Company agreed to reimburse each other for certain costs incurred in connection with their effort to implement the Merger Agreement.  During the nine months ended October 28, 2017 the Company incurred $1,113,000 of charges related to the proposed merger.

Over the last several years the Company has engaged in a series of management and organizational changes and, in connection therewith, retained consulting firms to review its costs and business strategy associated with such management and organizational changes.  The Company’s Board of Directors authorized changes to the Company’s chief executive function including the resignation of Anthony M. Romano as the Company’s Chief Executive Officer and President,  the September 17, 2017 appointment of B. Allen Weinstein, an independent member of the Company’s Board since 2010, as Interim Chief Executive Officer replacing Mr. Romano, the January 2, 2018 appointment of Melissa Payner-Gregor, an independent  member of the Company’s Board since 2009, as Interim Chief Executive Officer replacing Mr. Weinstein and the May 23, 2018 appointment of Marla Ryan as Chief Executive Officer replacing Ms. Payner-Gregor.  Ronald Masciantonio, the Company’s Chief Administrative Officer, resigned from his position on June 4, 2018.  David Stern, the Company’s former Chief Financial Officer departed the Company effective at the close of business on August 10, 2018. The Company also paid one-time retention bonuses with service conditions to certain key management personnel which are being recorded over the service period, while reducing its overall headcount to create a more efficient and effective operating structure. During the three and nine months ended November 3, 2018 and October 28, 2017 the Company incurred $1,742,000, $2,636,000, $2,674,000 and $2,633,000, respectively, of charges related to these management and organizational changes.

A summary of the net charges incurred in connection with the proxy solicitation and proposed merger and the management and organizational changes is as follows (in thousands):

	Three Months Ended				Nine Months Ended
	November 3, 2018		October 28, 2017		November 3, 2018		October 28, 2017
Proxy Solicitation and Proposed Merger
Proxy solicitation	$	83	$	—	$	2,224	$	—
Proposed merger		—		464		—		1,113
Total proxy solicitation and proposed    merger		83		464		2,224		1,113
Management and Organizational Changes
Severance and related benefits		1,252		2,139		2,136		2,136
Consulting fees		490		497		538		497
Total management and organizational    changes		1,742		2,636		2,674		2,633
Total other charges, net	$	1,825	$	3,100	$	4,898	$	3,746

XML

Government Incentives

9 Months Ended

Nov. 03, 2018

Government Incentives Disclosure [Abstract]

Government Incentives

11. GOVERNMENT INCENTIVES

In fiscal 2015 the Company completed the relocation of its corporate headquarters and distribution operations from Philadelphia, Pennsylvania to southern New Jersey. To partially offset the costs of these relocations, the Board of the New Jersey Economic Development Authority (“NJEDA”) approved the Company for an incentive package of up to $40,000,000 in benefits under the Grow New Jersey Assistance Program (“Grow NJ”) in the form of transferrable income tax credits over a ten-year period from the State of New Jersey. The award provides annually over a ten-year period up to $7,000 per eligible new full-time job, as defined under Grow NJ, with a requirement that at least 100 eligible jobs be created and subject to an annual award limit of $4,000,000.

The Grow NJ award requires an annual compliance report that includes certification of average annual employment figures after the end of each fiscal year. After the end of the ten-year Grow NJ award earnings period there is a five-year compliance period during which the Company must maintain the average of its annual eligible jobs certified during the preceding ten years or a pro-rata amount up to one-tenth of the previously awarded income tax credits would be subject to recapture and repayment to the State of New Jersey annually during the five-year compliance period. The Company believes the likelihood of any recapture and repayment is remote.

The annual benefit from the Grow NJ award available to the Company is expected to significantly exceed the Company’s annual income tax liability to the State of New Jersey. In order to maximize the realizable value of the incentive package, in December 2013 the Company entered into an agreement with a third party to sell 75% or more of the annual income tax credits awarded to the Company. The Company recognizes its Grow NJ award on an annual basis for each fiscal year based on the realizable value of the award earned and expected to be received, primarily from the sale of the income tax credits, net of any associated costs. The Grow NJ award is reflected in the Company’s consolidated financial statements as a reduction to the costs incurred by the Company in connection with the relocations. The expected realizable amount of the Grow NJ award is included in the consolidated balance sheet in deferred income taxes. As of November 3, 2018, the Company had recorded a deferred tax asset of $4,805,000 related to the NJ Grow award. Of this amount, $2,829,000 relates to the annual award earned in fiscal 2017, the cash proceeds of which is expected to be received in the fourth quarter of fiscal 2018. In April 2017, the Company received $3,251,000 cash proceeds, net of costs, from the receipt and subsequent sale of the $3,612,000 tax credit certificate earned for fiscal 2016. During the three and nine months ended November 3, 2018, the Company recognized the cost reduction related to the Grow NJ award in the amount of $617,000 and $1,902,000, respectively, as compared to the three and nine months ended October 28, 2017 in which the Company recognized $718,000 and $2,155,000 respectively.

XML

Income Taxes

9 Months Ended

Nov. 03, 2018

Income Tax Disclosure [Abstract]

Income Taxes

12. INCOME TAXES

The U.S. Tax Cuts and Jobs Act of 2017 (the “TCJA”) was signed into law on December 22, 2017.  The TCJA included a number of changes to the U.S. corporate income tax including a reduction of the corporate income tax rate from 35% to 21% for tax years beginning after December 31, 2017.  For fiscal 2018 the Company’s effective federal tax rate is 21%.  For fiscal 2017 the Company used a blended effective tax rate of 33.7% which represented the prorated percentage from the TCJA’s January 1, 2018 effective date and the Company’s February 3, 2018 fiscal year-end.  

Accounting Standards Codification (“ASC”) Topic 740, Income Taxes, requires that a valuation allowance be recorded to reduce deferred tax assets when it is more likely than not that the tax benefit of the deferred tax assets will not be realized. In situations where a three-year cumulative loss condition exists, accounting standards limit the ability to consider projections of future results as positive evidence to assess the realizability of deferred tax assets.  In fiscal 2016 the Company’s financial results reflected a three-year cumulative loss. Consequently, in fiscal 2016 the Company recorded a non-cash charge as a valuation allowance against substantially all of its deferred tax assets.  Three-year cumulative losses have continued in fiscal 2017 and fiscal 2018, consequently the Company continues to record a valuation allowance against its deferred tax assets.

XML

Equity Award Plans

9 Months Ended

Nov. 03, 2018

Disclosure Of Compensation Related Costs Sharebased Payments [Abstract]

Equity Award Plans

13. EQUITY AWARD PLANS

In January 2006, the stockholders of the Company approved the adoption of the Amended and Restated 2005 Equity Incentive Plan (the “2005 Plan”) and, subsequently, have approved amendments to increase the number of issuable shares under the 2015 Plan. Under the 2005 Plan, employees, directors, consultants and other individuals who provide services to the Company may be granted awards in the form of stock options, stock appreciation rights, restricted stock, RSU’s or deferred stock units. Up to 3,550,000 shares of the Company’s common stock may be issued in respect of awards under the 2005 Plan, as amended, with no more than 2,250,000 of those shares permitted to be issued in respect of restricted stock, RSU’s, or deferred stock units granted under the 2005 Plan. Awards of stock options to purchase the Company’s common stock will have exercise prices as determined by the Compensation Committee of the Board of Directors (the “Compensation Committee”), but such exercise prices may not be lower than the fair market value of the stock on the date of grant.

No stock options have been granted by the Company with an exercise price less than the fair market value of the Company’s common stock on the date of grant for any of the periods presented. The majority of the stock options issued under the 2005 Plan vest ratably over four-year periods and generally expire ten years from the date of grant. Restricted stock and time-based RSU awards issued under the 2005 Plan generally have restrictions that lapse ratably over periods ranging from one to four years however, up to 177,500 restricted stock awards may be issued with a vesting period of less than one year. Performance-based awards issued under the 2005 Plan generally vest based upon the achievement of pre-established performance goals over a specified three-year period. The number of shares of our common stock that may be earned in respect of performance-based awards may be greater or less than the target number of shares granted based on the actual performance achieved. The non-executive chairman of the Company’s Board of Directors is granted 6,000 shares of restricted stock on an annual bases and each non-employee director, other than the non-executive chairman, of the Company’s Board of Directors is granted 4,000 shares of restricted stock on an annual basis, in each case that will vest one year from the date of grant. The Company issues new shares of common stock upon exercise of vested stock options. As of November 3, 2018, there were 896,848 shares of the Company’s common stock available for grant under the 2005 Plan in the form of stock options, restricted stock, RSUs or deferred stock units.

Stock option activity for all plans was as follows:

	Outstanding Stock Options (in thousands)			Weighted Average Exercise Price		Weighted Average Remaining Life		Aggregate Intrinsic Value (in thousands)
Balance as of February 3, 2018	544			$	11.26
Granted	464			3.06
Exercised		—			—
Forfeited		(483	)	8.44
Expired		—			—
Balance as of November 3, 2018	525			$	6.62	8.4		$	598
Exercisable as of November 3, 2018	179			$	11.35		6.6		—

The following table summarizes information about stock options outstanding as of November 3, 2018:

	Stock Options Outstanding					Stock Options Exercisable
Range of Exercise Prices	Number Outstanding   (in thousands)	Weighted Average Remaining Life		Weighted Average Exercise Price		Number Exercisable (in thousands)		Weighted Average Exercise Price
$  2.65  to $  5.00	224		9.5	$	2.65		—	$	-
5.01  to   10.00	199		8.4		6.36	91			6.74
10.01  to   31.38	102		5.8		15.82	88			16.16
$  2.65  to  $31.38	525		8.4	$	6.62		179	$	11.35

The following table summarizes information about restricted stock and RSU activity for the 2005 Plan and includes 75,471 performance-based RSUs which is the number of RSUs that would be delivered if the target level of performance is achieved.  If performance was achieved at the maximum level, 150,942 RSUs would be delivered.  

	Outstanding Restricted Shares (in thousands)			Weighted Average Grant Date Fair Value
Unvested as of February 3, 2018		853		$	3.16
Granted		545			3.38
Vested		(144	)		3.81
Forfeited		(649	)		2.89
Unvested as of November 3, 2018		605		$	3.49

XML

Recent Accounting Pronouncements and Change in Accounting Principle

9 Months Ended

Nov. 03, 2018

New Accounting Pronouncements And Changes In Accounting Principles [Abstract]

Recent Accounting Pronouncements and Change in Accounting Principle

14. RECENT ACCOUNTING PRONOUNCEMENTS AND CHANGE IN ACCOUNTING PRINCIPLE

a. Newly Adopted Accounting Pronouncements

In May 2017 the Financial Accounting Standards Board (“FASB”) issued Accounting Standards Update (“ASU”) No. 2017-09, Compensation - Stock Compensation (Topic 718): Scope of Modification Accounting. ASU 2017-09 provides guidance about which changes to the terms or conditions of a share-based payment award require an entity to apply modification accounting in Topic 718. ASU No. 2017-09 is effective for financial statements issued for annual reporting periods beginning after December 15, 2017 and interim periods within those years. Earlier application is permitted. The Company adopted ASU No. 2017-09 effective February 4, 2018 and the adoption did not have a material impact on the Company’s consolidated financial position, results of operations or cash flows.

In October 2016 the FASB issued ASU No. 2016-16, Income Taxes (Topic 740): Intra-Entity Transfers of Assets Other Than Inventory. ASU No. 2016-16 amends the accounting for income taxes and requires the recognition of the income tax consequences of an intercompany asset transfer, other than transfers of inventory, when the transfer occurs. For intercompany transfers of inventory, the income tax effects will continue to be deferred until the inventory has been sold to a third party. ASU No. 2016-16 is effective for financial statements issued for annual reporting periods beginning after December 15, 2017 and interim periods within those years, using a modified retrospective application method through a cumulative-effect adjustment directly to retained earnings as of the beginning of the period of adoption. Earlier application is permitted. The Company adopted ASU No. 2016-16 effective February 4, 2018 and the adoption did not have a material impact on the Company’s consolidated financial position, results of operations or cash flows.

In August 2016 the FASB issued ASU No. 2016-15, Statement of Cash Flows (Topic 230): Classification of Certain Cash Receipts and Cash Payments. ASU No. 2016-15 clarifies and provides guidance on eight specific cash flow classification issues and is intended to reduce existing diversity in practice in how certain cash receipts and cash payments are presented and classified in the statement of cash flows. ASU No. 2016-15 is effective for annual reporting periods beginning after December 15, 2017 and interim periods within those years. Earlier application is permitted, provided that all of the amendments are adopted in the same period. The Company adopted ASU No. 2016-15 effective February 4, 2018 and the adoption did not have a material impact on the Company’s consolidated financial position, results of operations or cash flows.

In May 2014 the FASB issued ASU No. 2014-09, Revenue from Contracts with Customers (Topic 606). ASU No. 2014-09 requires an entity to recognize revenue for the amount of consideration to which it expects to be entitled for the transfer of promised goods or services to customers. Additionally, ASU No. 2014-09 requires improved disclosures to help users of financial statements better understand the nature, amount, timing, and uncertainty of revenue that is recognized. The standard replaced most existing revenue recognition guidance in GAAP when it became effective. ASU No. 2014-09 is effective for financial statements issued for annual reporting periods beginning after December 15, 2016 and interim periods within those years. In August 2015 the FASB issued ASU No. 2015-14, Revenue from Contracts with Customers (Topic 606): Deferral of the Effective Date which deferred the effective date of ASU No. 2014-09 by one year, making the guidance effective for fiscal years beginning after December 15, 2017.

Management adopted this guidance on February 3, 2018 using the modified retrospective approach.  This ASU required that sales return reserves be presented on a gross basis as a refund liability and an asset for recovery and that the asset be reported separate from inventory on the Company’s consolidated balance sheet.  Prior to the adoption of this ASU the Company had recorded its sales return reserve on a gross basis with the asset for recovery recorded as a component of inventory. The impact of adoption on the Company’s consolidated balance sheet as of November 3, 2018 is as follows:

						Excluding ASU
(in thousands)	As Reported		ASU 2014-09 Effect			2014-09 Effect
Inventories	$	79,054	$	(1,070	)		77,984
Prepaid expenses and other current assets		10,270		1,070			11,340

There was no impact from adoption on the Company’s consolidated statements of operations or consolidated statements of cash flow.  

b. Not Yet Adopted

In February 2016 the FASB issued ASU No. 2016-02, Leases (Topic 842). ASU No. 2016-02 affects any entity that enters into a lease (as that term is defined in the ASU) and its guidance supersedes Topic 840, Leases. As it substantively relates to the Company, ASU No. 2016-02 requires lessees to recognize a right-of-use asset and a lease liability, initially measured at the present value of the lease payments, in the statement of financial position. For finance leases, lessees are required to recognize interest on the lease liability separately from amortization of the right-of-use asset in the statement of comprehensive income and to classify repayments of the principal portion of the lease liability within financing activities and payments of interest on the lease liability and variable lease payments within operating activities in the statement of cash flows. For operating leases, lessees are required to recognize a single lease cost, calculated so that the cost of the lease is allocated over the lease term on a generally straight-line basis, and to classify all cash payments within operating activities in the statement of cash flows. In transition, lessees are required to recognize and measure leases at the beginning of the earliest period presented using a modified retrospective approach. ASU No. 2016-02 is effective for financial statements issued for annual reporting periods beginning after December 15, 2018 and interim periods within those years. Earlier application is permitted. The Company has implemented its leasing software solution and is in the process of validating output. We are also evaluating the provisions of this standard including the finalization of the use of practical expedients and assessing our existing lease portfolio in order to determine the impact on our accounting systems, processes and internal controls over financial reporting. While the Company is still evaluating this standard, given the significant number of leases the Company is party to, the Company expects this standard will have a material impact on the Company's consolidated financial statements. The standard will have no impact on our debt-covenant compliance under our current agreements.

In August 2018, the FASB issued ASU 2018-15, Customer's Accounting for Implementation Costs Incurred in a Cloud Computing Arrangement that is a Service Contract. ASU 2018-15 requires implementation costs incurred by customers in cloud computing arrangements to be deferred over the non-cancellable term of the cloud computing arrangements plus any optional renewal periods (1) that are reasonably certain to be exercised by the customer or (2) for which exercise of the renewal option is controlled by the cloud service provider. The effective date of this pronouncement is for fiscal years beginning after December 15, 2019, and interim periods within those fiscal years, and early adoption is permitted. The standard can be adopted either using the prospective or retrospective transition approach. The Company is currently evaluating the impact of this pronouncement on the Company's consolidated financial statements and disclosures.

XML

Commitments and Contingencies

9 Months Ended

Nov. 03, 2018

Commitments And Contingencies Disclosure [Abstract]

Commitments and Contingencies

15. COMMITMENTS AND CONTINGENCIES

From time to time, the Company is named as a defendant in legal actions arising from normal business activities. Litigation is inherently unpredictable, and although the amount of any liability that could arise with respect to currently pending actions cannot be accurately predicted, the Company does not believe that the resolution of any pending action will have a material adverse effect on its financial position, results of operations or liquidity.

XML

Segment and Enterprise Wide Disclosures

9 Months Ended

Nov. 03, 2018

Segment Reporting [Abstract]

Segment and Enterprise Wide Disclosures

16. SEGMENT AND ENTERPRISE WIDE DISCLOSURES

Operating Segment. For purposes of the disclosure requirements for segments of a business enterprise, the Company has determined that its business is comprised of one operating segment: the design, manufacture and sale of maternity apparel and related accessories. While the Company offers a wide range of products for sale, the substantial portion of its products are initially distributed through the same distribution facilities, many of the Company’s products are manufactured at common contract manufacturer production facilities, the Company’s products are marketed through a common marketing department, and these products are sold to a similar customer base consisting of expectant mothers.

Geographic Information. Geographic revenue information is allocated based on the country in which the products or services are sold, and in the case of international franchise revenues, on the location of the customer. Information concerning the Company’s operations by geographic area was as follows (in thousands):

	Three Months Ended				Nine Months Ended
	November 3, 2018		October 28, 2017		November 3, 2018		October 28, 2017
Net Sales
United States	$	88,006	$	90,584	$	278,057	$	283,676
Foreign		4,831		5,770		14,402		17,384

	November 3, 2018		February 3, 2018
Long-Lived Assets
United States	$	54,696	$	65,456
Foreign		1,325		1,643

Major Customers. For the periods presented, the Company did not have any one customer who represented more than 10% of its net sales.

XML

Interest Expense, Net

9 Months Ended

Nov. 03, 2018

Banking And Thrift Interest [Abstract]

Interest Expense, Net

17. INTEREST EXPENSE, NET

Interest expense, net was comprised of the following (in thousands):

	Three Months Ended					Nine Months Ended
	November 3, 2018			October 28, 2017		November 3, 2018			October 28, 2017
Interest expense	$	1,233		$	1,006	$	3,535		$	2,991
Interest income		(1	)		-		(2	)		(2	)
Interest expense, net	$	1,232		$	1,006	$	3,533		$	2,989

XML

Recent Accounting Pronouncements and Change in Accounting Principle (Policies)

9 Months Ended

Nov. 03, 2018

Accounting Policies [Abstract]

Newly Adopted Accounting Pronouncements

a. Newly Adopted Accounting Pronouncements

In May 2017 the Financial Accounting Standards Board (“FASB”) issued Accounting Standards Update (“ASU”) No. 2017-09, Compensation - Stock Compensation (Topic 718): Scope of Modification Accounting. ASU 2017-09 provides guidance about which changes to the terms or conditions of a share-based payment award require an entity to apply modification accounting in Topic 718. ASU No. 2017-09 is effective for financial statements issued for annual reporting periods beginning after December 15, 2017 and interim periods within those years. Earlier application is permitted. The Company adopted ASU No. 2017-09 effective February 4, 2018 and the adoption did not have a material impact on the Company’s consolidated financial position, results of operations or cash flows.

In October 2016 the FASB issued ASU No. 2016-16, Income Taxes (Topic 740): Intra-Entity Transfers of Assets Other Than Inventory. ASU No. 2016-16 amends the accounting for income taxes and requires the recognition of the income tax consequences of an intercompany asset transfer, other than transfers of inventory, when the transfer occurs. For intercompany transfers of inventory, the income tax effects will continue to be deferred until the inventory has been sold to a third party. ASU No. 2016-16 is effective for financial statements issued for annual reporting periods beginning after December 15, 2017 and interim periods within those years, using a modified retrospective application method through a cumulative-effect adjustment directly to retained earnings as of the beginning of the period of adoption. Earlier application is permitted. The Company adopted ASU No. 2016-16 effective February 4, 2018 and the adoption did not have a material impact on the Company’s consolidated financial position, results of operations or cash flows.

In August 2016 the FASB issued ASU No. 2016-15, Statement of Cash Flows (Topic 230): Classification of Certain Cash Receipts and Cash Payments. ASU No. 2016-15 clarifies and provides guidance on eight specific cash flow classification issues and is intended to reduce existing diversity in practice in how certain cash receipts and cash payments are presented and classified in the statement of cash flows. ASU No. 2016-15 is effective for annual reporting periods beginning after December 15, 2017 and interim periods within those years. Earlier application is permitted, provided that all of the amendments are adopted in the same period. The Company adopted ASU No. 2016-15 effective February 4, 2018 and the adoption did not have a material impact on the Company’s consolidated financial position, results of operations or cash flows.

In May 2014 the FASB issued ASU No. 2014-09, Revenue from Contracts with Customers (Topic 606). ASU No. 2014-09 requires an entity to recognize revenue for the amount of consideration to which it expects to be entitled for the transfer of promised goods or services to customers. Additionally, ASU No. 2014-09 requires improved disclosures to help users of financial statements better understand the nature, amount, timing, and uncertainty of revenue that is recognized. The standard replaced most existing revenue recognition guidance in GAAP when it became effective. ASU No. 2014-09 is effective for financial statements issued for annual reporting periods beginning after December 15, 2016 and interim periods within those years. In August 2015 the FASB issued ASU No. 2015-14, Revenue from Contracts with Customers (Topic 606): Deferral of the Effective Date which deferred the effective date of ASU No. 2014-09 by one year, making the guidance effective for fiscal years beginning after December 15, 2017.

Management adopted this guidance on February 3, 2018 using the modified retrospective approach.  This ASU required that sales return reserves be presented on a gross basis as a refund liability and an asset for recovery and that the asset be reported separate from inventory on the Company’s consolidated balance sheet.  Prior to the adoption of this ASU the Company had recorded its sales return reserve on a gross basis with the asset for recovery recorded as a component of inventory. The impact of adoption on the Company’s consolidated balance sheet as of November 3, 2018 is as follows:

						Excluding ASU
(in thousands)	As Reported		ASU 2014-09 Effect			2014-09 Effect
Inventories	$	79,054	$	(1,070	)		77,984
Prepaid expenses and other current assets		10,270		1,070			11,340

There was no impact from adoption on the Company’s consolidated statements of operations or consolidated statements of cash flow.  

Not Yet Adopted

b. Not Yet Adopted

In February 2016 the FASB issued ASU No. 2016-02, Leases (Topic 842). ASU No. 2016-02 affects any entity that enters into a lease (as that term is defined in the ASU) and its guidance supersedes Topic 840, Leases. As it substantively relates to the Company, ASU No. 2016-02 requires lessees to recognize a right-of-use asset and a lease liability, initially measured at the present value of the lease payments, in the statement of financial position. For finance leases, lessees are required to recognize interest on the lease liability separately from amortization of the right-of-use asset in the statement of comprehensive income and to classify repayments of the principal portion of the lease liability within financing activities and payments of interest on the lease liability and variable lease payments within operating activities in the statement of cash flows. For operating leases, lessees are required to recognize a single lease cost, calculated so that the cost of the lease is allocated over the lease term on a generally straight-line basis, and to classify all cash payments within operating activities in the statement of cash flows. In transition, lessees are required to recognize and measure leases at the beginning of the earliest period presented using a modified retrospective approach. ASU No. 2016-02 is effective for financial statements issued for annual reporting periods beginning after December 15, 2018 and interim periods within those years. Earlier application is permitted. The Company has implemented its leasing software solution and is in the process of validating output. We are also evaluating the provisions of this standard including the finalization of the use of practical expedients and assessing our existing lease portfolio in order to determine the impact on our accounting systems, processes and internal controls over financial reporting. While the Company is still evaluating this standard, given the significant number of leases the Company is party to, the Company expects this standard will have a material impact on the Company's consolidated financial statements. The standard will have no impact on our debt-covenant compliance under our current agreements.

In August 2018, the FASB issued ASU 2018-15, Customer's Accounting for Implementation Costs Incurred in a Cloud Computing Arrangement that is a Service Contract. ASU 2018-15 requires implementation costs incurred by customers in cloud computing arrangements to be deferred over the non-cancellable term of the cloud computing arrangements plus any optional renewal periods (1) that are reasonably certain to be exercised by the customer or (2) for which exercise of the renewal option is controlled by the cloud service provider. The effective date of this pronouncement is for fiscal years beginning after December 15, 2019, and interim periods within those fiscal years, and early adoption is permitted. The standard can be adopted either using the prospective or retrospective transition approach. The Company is currently evaluating the impact of this pronouncement on the Company's consolidated financial statements and disclosures.

XML

Earnings Per Share ("EPS") and Dividends (Tables)

9 Months Ended

Nov. 03, 2018

Earnings Per Share [Abstract]

Summary of Basic EPS and Diluted EPS Calculations

The following tables summarize the Basic EPS and Diluted EPS calculations (in thousands, except per share amounts):

	Three Months Ended
	November 3, 2018								October 28, 2017
	Net Loss			Shares		EPS			Net Loss			Shares		EPS
Basic and Diluted EPS	$	(4,114	)		13,895	$	(0.30	)	$	(7,523	)		13,800	$	(0.55	)

	Nine Months Ended
	November 3, 2018								October 28, 2017
	Net Loss			Shares		EPS			Net Loss			Shares		EPS
Basic and Diluted EPS	$	(7,925	)		13,867	$	(0.57	)	$	(11,439	)		13,777	$	(0.83	)

XML

Inventories (Tables)

9 Months Ended

Nov. 03, 2018

Inventory Disclosure [Abstract]

Inventories

Inventories were comprised of the following (in thousands):

	November 3, 2018		February 3, 2018
Finished goods	$	78,711	$	70,687
Work-in-progress		142		182
Raw materials		201		387
	$	79,054	$	71,256

XML

Accrued Expenses and Other Current Liabilities (Tables)

9 Months Ended

Nov. 03, 2018

Payables And Accruals [Abstract]

Accrued Expenses and Other Current Liabilities

Accrued expenses and other current liabilities were comprised of the following (in thousands):

	November 3, 2018		February 3, 2018
Employee compensation and benefits	$	6,256	$	7,133
Accrued expenses		4,866		3,244
Insurance, primarily self-insurance reserves		3,858		5,048
Deferred rent		2,983		3,211
Sales and use taxes		2,827		2,638
Gift certificates and store credits		2,832		3,385
Product return reserve		2,298		2,799
Deferred revenue		1,668		1,001
Audit and legal		1,399		714
Accrued property and equipment additions		185		218
Other		1,816		2,270
	$	30,988	$	31,661

XML

Net Sales (Tables)

9 Months Ended

Nov. 03, 2018

Revenues [Abstract]

Schedule of Disaggregation of Company's Net Sales by Major Source

The following disaggregates the Company’s net sales by major source (in thousands):

	Three Months Ended				Nine Months Ended
	November 3, 2018		October 28, 2017		November 3, 2018		October 28, 2017
Retail stores	$	55,979	$	59,325	$	177,608	$	191,664
Leased departments		9,743		10,292		29,624		32,752
Total retail locations		65,722		69,617		207,232		224,416
Ecommerce		21,045		20,539		69,530		57,615
Marketing partnerships		4,110		4,475		12,236		13,004
Wholesale and franchise		1,960		1,723		3,461		6,025
Total net sales	$	92,837	$	96,354	$	292,459	$	301,060

XML

Other Charges, Net (Tables)

9 Months Ended

Nov. 03, 2018

Other Charges Net Related To Proxy Solicitation And Proposed Merger And Management And Organizational Changes [Abstract]

Summary of Net Charges Incurred in Proxy Solicitation and Proposed Merger and Management and Organizational Changes

A summary of the net charges incurred in connection with the proxy solicitation and proposed merger and the management and organizational changes is as follows (in thousands):

	Three Months Ended				Nine Months Ended
	November 3, 2018		October 28, 2017		November 3, 2018		October 28, 2017
Proxy Solicitation and Proposed Merger
Proxy solicitation	$	83	$	—	$	2,224	$	—
Proposed merger		—		464		—		1,113
Total proxy solicitation and proposed    merger		83		464		2,224		1,113
Management and Organizational Changes
Severance and related benefits		1,252		2,139		2,136		2,136
Consulting fees		490		497		538		497
Total management and organizational    changes		1,742		2,636		2,674		2,633
Total other charges, net	$	1,825	$	3,100	$	4,898	$	3,746

XML

Equity Award Plans (Tables)

9 Months Ended

Nov. 03, 2018

Disclosure Of Compensation Related Costs Sharebased Payments [Abstract]

Stock Option Activity for All Plans

Stock option activity for all plans was as follows:

	Outstanding Stock Options (in thousands)			Weighted Average Exercise Price		Weighted Average Remaining Life		Aggregate Intrinsic Value (in thousands)
Balance as of February 3, 2018	544			$	11.26
Granted	464			3.06
Exercised		—			—
Forfeited		(483	)	8.44
Expired		—			—
Balance as of November 3, 2018	525			$	6.62	8.4		$	598
Exercisable as of November 3, 2018	179			$	11.35		6.6		—

Summarizes Information about Stock Options Outstanding

The following table summarizes information about stock options outstanding as of November 3, 2018:

	Stock Options Outstanding					Stock Options Exercisable
Range of Exercise Prices	Number Outstanding   (in thousands)	Weighted Average Remaining Life		Weighted Average Exercise Price		Number Exercisable (in thousands)		Weighted Average Exercise Price
$  2.65  to $  5.00	224		9.5	$	2.65		—	$	-
5.01  to   10.00	199		8.4		6.36	91			6.74
10.01  to   31.38	102		5.8		15.82	88			16.16
$  2.65  to  $31.38	525		8.4	$	6.62		179	$	11.35

Restricted Stock Activity

The following table summarizes information about restricted stock and RSU activity for the 2005 Plan and includes 75,471 performance-based RSUs which is the number of RSUs that would be delivered if the target level of performance is achieved.  If performance was achieved at the maximum level, 150,942 RSUs would be delivered.  

	Outstanding Restricted Shares (in thousands)			Weighted Average Grant Date Fair Value
Unvested as of February 3, 2018		853		$	3.16
Granted		545			3.38
Vested		(144	)		3.81
Forfeited		(649	)		2.89
Unvested as of November 3, 2018		605		$	3.49

XML

Recent Accounting Pronouncements and Change in Accounting Principle (Tables)

9 Months Ended

Nov. 03, 2018

ASU 2014-09

Impact of Adoption on Consolidated Balance Sheet

The impact of adoption on the Company’s consolidated balance sheet as of November 3, 2018 is as follows:

						Excluding ASU
(in thousands)	As Reported		ASU 2014-09 Effect			2014-09 Effect
Inventories	$	79,054	$	(1,070	)		77,984
Prepaid expenses and other current assets		10,270		1,070			11,340

XML

Segment and Enterprise Wide Disclosures (Tables)

9 Months Ended

Nov. 03, 2018

Segment Reporting [Abstract]

Operations by Geographic Area

Geographic Information. Geographic revenue information is allocated based on the country in which the products or services are sold, and in the case of international franchise revenues, on the location of the customer. Information concerning the Company’s operations by geographic area was as follows (in thousands):

	Three Months Ended				Nine Months Ended
	November 3, 2018		October 28, 2017		November 3, 2018		October 28, 2017
Net Sales
United States	$	88,006	$	90,584	$	278,057	$	283,676
Foreign		4,831		5,770		14,402		17,384

	November 3, 2018		February 3, 2018
Long-Lived Assets
United States	$	54,696	$	65,456
Foreign		1,325		1,643

XML

Interest Expense, Net (Tables)

9 Months Ended

Nov. 03, 2018

Banking And Thrift Interest [Abstract]

Interest Expense, Net

Interest expense, net was comprised of the following (in thousands):

	Three Months Ended					Nine Months Ended
	November 3, 2018			October 28, 2017		November 3, 2018			October 28, 2017
Interest expense	$	1,233		$	1,006	$	3,535		$	2,991
Interest income		(1	)		-		(2	)		(2	)
Interest expense, net	$	1,232		$	1,006	$	3,533		$	2,989

XML

Earnings Per Share ("EPS") and Dividends - Summary of Basic EPS and Diluted EPS Calculations (Details) - USD ($) $ / shares in Units, shares in Thousands, $ in Thousands	3 Months Ended		9 Months Ended
	Nov. 03, 2018	Oct. 28, 2017	Nov. 03, 2018	Oct. 28, 2017
Earnings Per Share [Abstract]
Net Loss	$ (4,114)	$ (7,523)	$ (7,925)	$ (11,439)
Basic and Diluted shares	13,895	13,800	13,867	13,777
Basic and Diluted EPS	$ (0.30)	$ (0.55)	$ (0.57)	$ (0.83)

XML

Earnings Per Share ("EPS") and Dividends - Additional Information (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Nov. 03, 2018	Oct. 28, 2017	Nov. 03, 2018	Oct. 28, 2017
Earnings Per Share Diluted [Line Items]
Options and unvested restricted stock	436,000	804,000	1,130,000	1,604,000
Weighted average number of diluted shares outstanding	13,895,000	13,800,000	13,867,000	13,777,000
Dividends forfeited			$ 7	$ 15
Pro Forma
Earnings Per Share Diluted [Line Items]
Weighted average number of diluted shares outstanding	14,186,000	13,811,000	14,159,000	13,797,000

XML

Trade Receivables - Additional Information (Details) - USD ($) $ in Thousands	Nov. 03, 2018	Feb. 03, 2018
Receivables [Abstract]
Trade receivables, allowance for doubtful accounts	$ 166	$ 166

XML

Inventories - Inventories (Details) - USD ($) $ in Thousands	Nov. 03, 2018	Feb. 03, 2018
Inventory Disclosure [Abstract]
Finished goods	$ 78,711	$ 70,687
Work-in-progress	142	182
Raw materials	201	387
Total	$ 79,054	$ 71,256

XML

Accrued Expenses and Other Current Liabilities - Accrued Expenses and Other Current Liabilities (Details) - USD ($) $ in Thousands	Nov. 03, 2018	Feb. 03, 2018
Payables and Accruals [Abstract]
Employee compensation and benefits	$ 6,256	$ 7,133
Accrued expenses	4,866	3,244
Insurance, primarily self-insurance reserves	3,858	5,048
Deferred rent	2,983	3,211
Sales and use taxes	2,827	2,638
Gift certificates and store credits	2,832	3,385
Product return reserve	2,298	2,799
Deferred revenue	1,668	1,001
Audit and legal	1,399	714
Accrued property and equipment additions	185	218
Other	1,816	2,270
Total accrued expenses and other current liabilities	$ 30,988	$ 31,661

XML

Line of Credit - Additional Information (Details) - USD ($)			3 Months Ended		9 Months Ended
	Sep. 26, 2018	Feb. 01, 2018	Nov. 03, 2018	Oct. 28, 2017	Nov. 03, 2018	Oct. 28, 2017	Feb. 03, 2018	Mar. 25, 2016
Line Of Credit Facility [Line Items]
Minimum excess availability on Combined Loan Cap			10.00%		10.00%
Minimum amount excess availability on Combined Loan Cap			$ 7,000,000		$ 7,000,000
Payment of financing costs					160,000	$ 277,000
Outstanding borrowings under Credit Facility			21,700,000	$ 8,200,000	21,700,000	8,200,000	$ 8,000,000
Letters of credit			7,327,000	7,327,000	7,327,000	7,327,000
Line of credit availability			$ 13,505,000	$ 12,531,000	$ 13,505,000	$ 12,531,000
Borrowings interest rate			4.22%	3.87%	4.11%	3.51%
Line of credit, outstanding borrowings					$ 17,258,000	$ 8,707,000
Line of credit borrowings during period					$ 27,400,000	$ 15,700,000
Asset-based senior secured facilities committed period	5 years
Term Loan
Line Of Credit Facility [Line Items]
Loan available for borrowing		$ 25,000,000
Minimum excess availability on Combined Loan Cap		10.00%
Minimum amount excess availability on Combined Loan Cap		$ 7,000,000
Credit Facility Description of Variable Rate Basis					The interest rate on the Term Loan is equal to a LIBOR rate plus 9.0%.
Term Loan | Maximum
Line Of Credit Facility [Line Items]
Loan available for borrowing		$ 25,000,000
Term Loan | London Interbank Offered Rate (LIBOR)
Line Of Credit Facility [Line Items]
Applicable margin rate		9.00%
Senior Secured Revolving Credit Facility
Line Of Credit Facility [Line Items]
Credit facility, maximum borrowing capacity		$ 50,000,000
Unused line fee under the Credit Facility					0.25%
Credit Facility Description of Variable Rate Basis					The interest rate on outstanding borrowings is equal to, at the Company’s election, either 1) the lender’s base rate plus 0.50% or 2) a LIBOR rate plus 1.0%.
Deferred financing costs							$ 1,280,000
Senior Secured Revolving Credit Facility | Base Rate
Line Of Credit Facility [Line Items]
Applicable margin rate					0.50%
Senior Secured Revolving Credit Facility | London Interbank Offered Rate (LIBOR)
Line Of Credit Facility [Line Items]
Applicable margin rate					1.00%
Senior Secured Revolving Credit Facility | Credit Facility
Line Of Credit Facility [Line Items]
Credit facility, maximum borrowing capacity								$ 70,000,000
Senior Secured Revolving Credit Facility | Term Loan
Line Of Credit Facility [Line Items]
Line of credit maturity date extension					Jan. 31, 2023
ABL
Line Of Credit Facility [Line Items]
Credit facility, maximum borrowing capacity	$ 52,000,000
ABL | Base Rate | Minimum
Line Of Credit Facility [Line Items]
Applicable margin rate	0.50%
ABL | Base Rate | Maximum
Line Of Credit Facility [Line Items]
Applicable margin rate	1.00%
ABL | London Interbank Offered Rate (LIBOR) | Minimum
Line Of Credit Facility [Line Items]
Applicable margin rate	1.50%
ABL | London Interbank Offered Rate (LIBOR) | Maximum
Line Of Credit Facility [Line Items]
Applicable margin rate	2.00%
FILO Term Loan
Line Of Credit Facility [Line Items]
Loan available for borrowing	$ 24,000,000
FILO Term Loan | Base Rate | Minimum
Line Of Credit Facility [Line Items]
Applicable margin rate	2.25%
FILO Term Loan | Base Rate | Maximum
Line Of Credit Facility [Line Items]
Applicable margin rate	2.75%
FILO Term Loan | London Interbank Offered Rate (LIBOR) | Minimum
Line Of Credit Facility [Line Items]
Applicable margin rate	3.25%
FILO Term Loan | London Interbank Offered Rate (LIBOR) | Maximum
Line Of Credit Facility [Line Items]
Applicable margin rate	3.75%

XML

Long-Term Debt - Additional Information (Details) - USD ($)					4 Months Ended	9 Months Ended
	Sep. 26, 2018	Feb. 01, 2018	Jun. 06, 2017	Mar. 25, 2016	Jan. 31, 2015	Nov. 03, 2018	Oct. 28, 2017	Jul. 16, 2018	Apr. 07, 2017
Debt Instrument [Line Items]
Proceeds from long-term debt						$ 2,500,000	$ 3,401,000
Payments of Financing Costs						$ 160,000	277,000
Minimum excess availability on Combined Loan Cap						10.00%
Minimum amount excess availability on Combined Loan Cap						$ 7,000,000
Asset-based senior secured facilities committed period	5 years
Sale and leaseback, transaction date						June 6, 2017
Sale and leaseback transaction, financing agreement period			3 years
Sale and leaseback, description of assets						certain furniture, fixtures and software
Monthly payments for first 24 months			$ 123,000
Monthly payments under leaseback arrangement for 25 to 36 months			48,000
Sale and leaseback, payment terms						Monthly payments under the leaseback arrangement are $123,000 for the first 24 months and $48,000 for months 25 to 36.
Principal outstanding						$ 1,680,000	2,947,000
Equipment Loan
Debt Instrument [Line Items]
Principal outstanding under equipment note						$ 3,730,000	7,064,000
Equipment financing arrangement period						5 years
Percentage of interest on equipment financing arrangement					3.38%
Monthly payments for equipment financing arrangement					$ 272,000
Debt instrument maturity date					Dec. 31, 2019
ABL
Debt Instrument [Line Items]
Credit facility, maximum borrowing capacity	$ 52,000,000
FILO Term Loan
Debt Instrument [Line Items]
Loan available for borrowing	$ 24,000,000
Minimum | London Interbank Offered Rate (LIBOR) | ABL
Debt Instrument [Line Items]
Applicable margin rate	1.50%
Minimum | London Interbank Offered Rate (LIBOR) | FILO Term Loan
Debt Instrument [Line Items]
Applicable margin rate	3.25%
Minimum | Base Rate | ABL
Debt Instrument [Line Items]
Applicable margin rate	0.50%
Minimum | Base Rate | FILO Term Loan
Debt Instrument [Line Items]
Applicable margin rate	2.25%
Maximum | London Interbank Offered Rate (LIBOR) | ABL
Debt Instrument [Line Items]
Applicable margin rate	2.00%
Maximum | London Interbank Offered Rate (LIBOR) | FILO Term Loan
Debt Instrument [Line Items]
Applicable margin rate	3.75%
Maximum | Base Rate | ABL
Debt Instrument [Line Items]
Applicable margin rate	1.00%
Maximum | Base Rate | FILO Term Loan
Debt Instrument [Line Items]
Applicable margin rate	2.75%
Term Loan
Debt Instrument [Line Items]
Loan available for borrowing		$ 25,000,000
Line of credit maturity date		Jan. 31, 2023
Proceeds from long-term debt		$ 22,500,000
Proceeds from loan		3,600,000
Additional loan available for borrowing		$ 2,500,000
Period of delivery to the lender		45 days
Additional loan amount borrowed								$ 2,500,000
Minimum excess availability on Combined Loan Cap		10.00%
Minimum amount excess availability on Combined Loan Cap		$ 7,000,000
Credit Facility Description of Variable Rate Basis						The interest rate on the Term Loan is equal to a LIBOR rate plus 9.0%.
Debt Instrument, frequency of periodic payment						Quarterly
Debt instrument, payment terms						The Term Loan can be prepaid at the Company's option subject to certain restrictions and subject to a prepayment premium as follows: 1) if the prepayment occurs on or prior to the second anniversary of the Closing Date, the greater of??a) interest on the prepayment that would otherwise have been paid with the 24 month period following the Closing Date minus actual interest payments made through the prepayment date and b) 2% of the prepayment and 2) 2% of the prepayment amount if paid between the second and third anniversary of the Closing Date.
Debt Instrument, frequency of periodic payment, commencing date						Jul. 31, 2018
Dividends payment or share repurchases prohibition period						3 years
Deferred financing costs						$ 2,460,000
Principal outstanding						$ 24,375,000
Proceeds from equipment financing transaction			$ 3,401,000
Term Loan | London Interbank Offered Rate (LIBOR)
Debt Instrument [Line Items]
Applicable margin rate		9.00%
Term Loan | Minimum
Debt Instrument [Line Items]
Debt instruments, periodic payments, principal		$ 312,500
Term Loan | Maximum
Debt Instrument [Line Items]
Loan available for borrowing		25,000,000
Prior Term Loan Agreement
Debt Instrument [Line Items]
Line of credit maturity date				Mar. 25, 2021
Repayment of existing balance		22,999,000
Payments of Financing Costs		3,226,000
Minimum excess availability on Combined Loan Cap									10.00%
Minimum amount excess availability on Combined Loan Cap									$ 10,000,000
Credit Facility Description of Variable Rate Basis						The interest rate on the Prior Term Loan was equal to a LIBOR rate (with a 1.0% LIBOR floor) plus 7.5%.
Long-term debt				$ 32,000,000
Additional reserve against availability under credit facility that will be reduced for prepayment of term loan									$ 5,000,000
Deferred financing costs		4,557,000
Loss on extinguishment of debt		$ (1,542,000)
Principal outstanding							$ 24,599,000
Prior Term Loan Agreement | London Interbank Offered Rate (LIBOR)
Debt Instrument [Line Items]
Applicable margin rate				7.50%
Debt instrument, interest rate				1.00%
Prior Term Loan Agreement | Minimum
Debt Instrument [Line Items]
Debt instruments, periodic payments, principal				$ 800,000

XML

Fair Value Measurements - Additional Information (Details) - USD ($) $ in Thousands	Nov. 03, 2018	Feb. 03, 2018	Oct. 28, 2017
Fair Value Balance Sheet Grouping Financial Statement Captions [Line Items]
Cash equivalents held by the Company	$ 4	$ 4
Outstanding borrowings under Credit Facility	$ 21,700	$ 8,000	$ 8,200
Term Loan | Minimum
Fair Value Balance Sheet Grouping Financial Statement Captions [Line Items]
Annual variable interest rate	9.00%

XML

Net Sales - Schedule of Disaggregation of Company's Net Sales by Major Source (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Nov. 03, 2018	Oct. 28, 2017	Nov. 03, 2018	Oct. 28, 2017
Disaggregation of Revenue [Line Items]
Total net sales	$ 92,837	$ 96,354	$ 292,459	$ 301,060
Retail Stores [Member]
Disaggregation of Revenue [Line Items]
Total net sales	55,979	59,325	177,608	191,664
Leased Departments [Member]
Disaggregation of Revenue [Line Items]
Total net sales	9,743	10,292	29,624	32,752
Total Retail Locations [Member]
Disaggregation of Revenue [Line Items]
Total net sales	65,722	69,617	207,232	224,416
Ecommerce [Member]
Disaggregation of Revenue [Line Items]
Total net sales	21,045	20,539	69,530	57,615
Marketing Partnerships [Member]
Disaggregation of Revenue [Line Items]
Total net sales	4,110	4,475	12,236	13,004
Wholesale and Franchisee [Member]
Disaggregation of Revenue [Line Items]
Total net sales	$ 1,960	$ 1,723	$ 3,461	$ 6,025

XML

Other Charges, Net - Additional Information (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Nov. 03, 2018	Oct. 28, 2017	Nov. 03, 2018	Oct. 28, 2017
Other Charges Net Related To Proxy Solicitation And Proposed Merger And Management And Organizational Changes [Line Items]
Charges related to proxy solicitation	$ 83		$ 2,224
Charges related to Merger		$ 464		$ 1,113
Charges related to management and organizational changes	$ 1,742	$ 2,636	$ 2,674	$ 2,633
Orchestra-Premaman S.A., and Certain Other Affiliates of Orchestra
Other Charges Net Related To Proxy Solicitation And Proposed Merger And Management And Organizational Changes [Line Items]
Termination agreement entry date			Jul. 27, 2017

XML

Other Charges, Net - Summary of Net Charges Incurred in Proxy Solicitation and Proposed Merger and Management and Organizational Changes (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Nov. 03, 2018	Oct. 28, 2017	Nov. 03, 2018	Oct. 28, 2017
Proxy Solicitation and Proposed Merger
Proxy solicitation	$ 83		$ 2,224
Proposed merger		$ 464		$ 1,113
Total proxy solicitation and proposed merger	83	464	2,224	1,113
Management and Organizational Changes
Severance and related benefits	1,252	2,139	2,136	2,136
Consulting fees	490	497	538	497
Total management and organizational changes	1,742	2,636	2,674	2,633
Total other charges, net	$ 1,825	$ 3,100	$ 4,898	$ 3,746

XML

Government Incentives - Additional Information (Details) $ in Thousands	1 Months Ended	3 Months Ended		9 Months Ended		12 Months Ended
	Apr. 29, 2017 USD ($)	Nov. 03, 2018 USD ($)	Oct. 28, 2017 USD ($)	Nov. 03, 2018 USD ($) Job	Oct. 28, 2017 USD ($)	Jan. 28, 2017 USD ($)	Feb. 03, 2018 USD ($)
Government Incentive Assistance Program [Line Items]
Deferred tax assets		$ 4,805		$ 4,805			$ 2,829
Grow New Jersey Assistance Program (Grow NJ)
Government Incentive Assistance Program [Line Items]
Income tax credits granted from state incentive package		40,000		$ 40,000
Transferrable income tax credit period				10 years
Government incentive assistance program award period				10 years
Project development, eligible amount per new full time job				$ 7
Government incentive assistance program annual award limit				$ 4,000
Award compliance period				5 years
Award Compliance Description				After the end of the ten-year Grow NJ award earnings period there is a five-year compliance period during which the Company must maintain the average of its annual eligible jobs certified during the preceding ten years or a pro-rata amount up to one-tenth of the previously awarded income tax credits would be subject to recapture and repayment to the State of New Jersey annually during the five-year compliance period.
Agreement to sell annual income tax credits awarded, Description				75% or more
Deferred tax assets		4,805		$ 4,805			$ 2,829
Cash proceeds net of costs from government incentive assistance program	$ 3,251
Income tax credits earned from state incentive package						$ 3,612
Cost reduction related to award		$ 617	$ 718	$ 1,902	$ 2,155
Grow New Jersey Assistance Program (Grow NJ) | Minimum
Government Incentive Assistance Program [Line Items]
Government incentive assistance program number of eligible jobs | Job				100

XML

Income Taxes - Additional Information (Details)	9 Months Ended	11 Months Ended	12 Months Ended
	Nov. 03, 2018	Dec. 31, 2017	Feb. 03, 2018
Income Tax Disclosure [Abstract]
Corporate tax rate	21.00%	35.00%	33.70%

XML

Equity Award Plans - Additional Information (Details) - shares	9 Months Ended	12 Months Ended
	Nov. 03, 2018	Feb. 03, 2018
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]
Number of stock options granted with exercise price less than fair market value on grant date	0	0
Non-employee director
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]
Share-based payment award, vesting period	1 year
Restricted stock, shares vested	4,000
2005 Plan
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]
Options to be issued	3,550,000
Common stock shares issued, restricted stock units or deferred stock units	2,250,000
Common stock available for grant	896,848
Target cumulative performance-based restricted stock units available for future declaration	75,471
Maximum cumulative restricted stock units available for future declaration	150,942
2005 Plan | Employee Stock Option
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]
Share-based payment award, vesting period	4 years
Share-based payment award, expiration period	10 years
2005 Plan | Restricted Stock
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]
Share-based payment award, vesting period	1 year
Awards that may be issued	177,500
2005 Plan | Performance-Based Awards
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]
Performance period	3 years
2005 Plan | Maximum | Restricted Stock and Time-Based RSU
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]
Share-based payment award, expiration period	4 years
2005 Plan | Minimum | Restricted Stock and Time-Based RSU
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]
Share-based payment award, expiration period	1 year
Non-executive chairman
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]
Share-based payment award, vesting period	1 year
Restricted stock, shares vested	6,000

XML

Equity Award Plans - Stock Option Activity for All Plans (Details) $ / shares in Units, shares in Thousands, $ in Thousands	9 Months Ended
	Nov. 03, 2018 USD ($) $ / shares shares
Disclosure Of Compensation Related Costs Sharebased Payments [Abstract]
Outstanding Stock Options, Beginning balance | shares	544
Outstanding Stock Options, Granted | shares	464
Outstanding Stock Options, Forfeited | shares	(483)
Outstanding Stock Options, Ending balance | shares	525
Outstanding Stock Options, Exercisable | shares	179
Weighted Average Exercise Price, Beginning balance | $ / shares	$ 11.26
Weighted Average Exercise Price, Granted | $ / shares	3.06
Weighted Average Exercise Price, Forfeited | $ / shares	8.44
Weighted Average Exercise Price, Ending balance | $ / shares	6.62
Weighted Average Exercise Price, Exercisable | $ / shares	$ 11.35
Weighted Average Remaining Life, Outstanding	8 years 4 months 24 days
Weighted Average Remaining Life, Exercisable	6 years 7 months 6 days
Aggregate Intrinsic Value, Ending balance | $	$ 598

XML

Equity Award Plans - Summarizes Information about Stock Options Outstanding (Details) shares in Thousands	9 Months Ended
	Nov. 03, 2018 $ / shares shares
2.65 to $ 5.00
Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range [Line Items]
Range of Exercise Prices, lower range	$ 2.65
Range of Exercise Prices, upper range	$ 5.00
Stock Options Outstanding, Number Outstanding | shares	224
Stock Options Outstanding, Weighted Average Remaining Life	9 years 6 months
Stock Options Outstanding, Weighted Average Exercise Price	$ 2.65
5.01 to 10.00
Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range [Line Items]
Range of Exercise Prices, lower range	5.01
Range of Exercise Prices, upper range	$ 10.00
Stock Options Outstanding, Number Outstanding | shares	199
Stock Options Outstanding, Weighted Average Remaining Life	8 years 4 months 24 days
Stock Options Outstanding, Weighted Average Exercise Price	$ 6.36
Stock Options Exercisable, Number Exercisable | shares	91
Stock Options Exercisable, Weighted Average Exercise Price	$ 6.74
10.01 to 31.38
Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range [Line Items]
Range of Exercise Prices, lower range	10.01
Range of Exercise Prices, upper range	$ 31.38
Stock Options Outstanding, Number Outstanding | shares	102
Stock Options Outstanding, Weighted Average Remaining Life	5 years 9 months 18 days
Stock Options Outstanding, Weighted Average Exercise Price	$ 15.82
Stock Options Exercisable, Number Exercisable | shares	88
Stock Options Exercisable, Weighted Average Exercise Price	$ 16.16
2.65 to $31.38
Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range [Line Items]
Range of Exercise Prices, lower range	2.65
Range of Exercise Prices, upper range	$ 31.38
Stock Options Outstanding, Number Outstanding | shares	525
Stock Options Outstanding, Weighted Average Remaining Life	8 years 4 months 24 days
Stock Options Outstanding, Weighted Average Exercise Price	$ 6.62
Stock Options Exercisable, Number Exercisable | shares	179
Stock Options Exercisable, Weighted Average Exercise Price	$ 11.35

XML

Equity Award Plans - Restricted Stock Activity (Details) shares in Thousands	9 Months Ended
	Nov. 03, 2018 $ / shares shares
Restricted stock activity for the 2005 Plan
Outstanding Restricted Shares, Unvested, beginning balance | shares	853
Outstanding Restricted Shares, Granted | shares	545
Outstanding Restricted Shares, Vested | shares	(144)
Outstanding Restricted Shares, Forfeited | shares	(649)
Outstanding Restricted Shares, Unvested, ending balance | shares	605
Weighted Average Grant Date Fair Value, Unvested, beginning balance | $ / shares	$ 3.16
Weighted Average Grant Date Fair Value, Granted | $ / shares	3.38
Weighted Average Grant Date Fair Value, Vested | $ / shares	3.81
Weighted Average Grant Date Fair Value, Forfeited | $ / shares	2.89
Weighted Average Grant Date Fair Value, Unvested, ending balance | $ / shares	$ 3.49

XML

Recent Accounting Pronouncements and Change in Accounting Principle - Impact of Adoption on Consolidated Balance Sheet (Details) - USD ($) $ in Thousands	Nov. 03, 2018	Feb. 03, 2018
Revenue Initial Application Period Cumulative Effect Transition [Line Items]
Inventories	$ 79,054	$ 71,256
Prepaid expenses and other current assets	10,270	$ 11,522
ASU 2014-09 | ASU 2014-09 Effect
Revenue Initial Application Period Cumulative Effect Transition [Line Items]
Inventories	(1,070)
Prepaid expenses and other current assets	1,070
ASU 2014-09 | Excluding ASU 2014-09 Effect
Revenue Initial Application Period Cumulative Effect Transition [Line Items]
Inventories	77,984
Prepaid expenses and other current assets	$ 11,340

XML

Segment and Enterprise Wide Disclosures - Additional Information (Details)	9 Months Ended
	Nov. 03, 2018 Segment Customer
Disclosure Segment And Enterprise Wide Disclosures Additional Information Detail [Abstract]
Number of operating segment | Segment	1
Number of customer who represented more than 10% of net sales | Customer	0

XML

Segment and Enterprise Wide Disclosures - Operations by Geographic Area (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Nov. 03, 2018	Oct. 28, 2017	Nov. 03, 2018	Oct. 28, 2017	Feb. 03, 2018
Net Sales
Net sales	$ 92,837	$ 96,354	$ 292,459	$ 301,060
United States
Net Sales
Net sales	88,006	90,584	278,057	283,676
Long-Lived Assets
Long-Lived Assets	54,696		54,696		$ 65,456
Foreign
Net Sales
Net sales	4,831	$ 5,770	14,402	$ 17,384
Long-Lived Assets
Long-Lived Assets	$ 1,325		$ 1,325		$ 1,643

XML

Interest Expense, Net - Interest Expense, Net (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Nov. 03, 2018	Oct. 28, 2017	Nov. 03, 2018	Oct. 28, 2017
Interest expense, net
Interest expense	$ 1,233	$ 1,006	$ 3,535	$ 2,991
Interest income	(1)		(2)	(2)
Interest expense, net	$ 1,232	$ 1,006	$ 3,533	$ 2,989